Abstract
In this chapter, I will review information on mechanisms of immune renal diseases published only during 1986-1987, with particular attention to new directions, concepts, and processes that may have significant implications for the future. In setting this course, I inevitably exclude from review isolated observations of interest that do not blend easily into currents of the field in general. In the second half of the chapter, I will review new data on clinical entities considered in the category of immune renal disease. Whenever possible, I have linked observations on disease mechanisms made experimentally with the clinical entities that are believed to result from them.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andres, G., Brentjens, J.R., Caldwell, P.R.B., Camussi, G., and Matsuo, S., 1986, Biology of disease. Formation of immune deposits and disease, Lab. Invest. 55:510–520.
Wener, M.H. and Mannik, M., 1986, Mechanisms of immune deposit formation in renal glomeruli, Springer Semin. Immunopathol. 9:219–235.
Feintzeig, I.D., Dittmer, J.E., Cybulsky, A.V., and Salant, D.J., 1986, Antibody, antigen, and glomerular capillary wall charge interactions: Influence of antigen location on in situ immune complex formation, Kidney Int. 29:649–657.
Ronco, P., Neale, T.J., Wilson, C.B., Galceran, M., and Verroust, P., 1986, An immunopathologic study of A 330-kD protein defined by monoclonal antibodies and reactive with anti- RTEα 5 antibodies and kidney eluates from active Heymann nephritis, J. Immunol. 136:125–130.
Kerjaschki, D., Horvat, R., Binder, S., Susani, M., Dekan, G., Ojha, P.P., Hillemanns, P., Ulrich, W., and Donini, U., 1987, Identification of a 400-kd protein in the brush borders of human kidney tubules that is similar to gp330, the nephritogenic antigen of rat Heymann nephritis, Am. J. Pathol. 129:183–191.
Behar, M., Katz, A., and Silverman, M., 1986, Biochemical investigation of the pathogenesis of Heymann nephritis, Kidney Int. 30:9–15.
Natori, Y., Hayakawa, I., and Shibata, S., 1987, Heymann nephritis in rats induced by human renal tubular antigens: characterization of antigen and antibody specificities, Clin. Exp. Immunol. 69:33–40.
Singh, A.K. and Makker, S.P., 1986, Circulatory antigens of Heymann nephritis I. Identification and partial characterization, Immunology 57:467–472.
Singh, A.K. and Schwartz, M.M., 1986, Circulatory antigen of Heymann nephritis. II. Isolation of a 70,000 MW antigen from normal rat serum which cross-reacts with Heymann nephritis antigen, Immunology 59:451–458.
Makker, S.P. and Makker, D.M., 1986, A simple technique for detecting the antigen of Heymann nephritis in glomeruli by immunofluorescence, Clin. Exp. Immunol. 64:615–622.
Abrass, C.K. and Cohen, A.H., 1986, The role of circulating antigen in the formation of immune deposits in experimental membranous nephropathy, Proc. Soc. Exp. Biol. Med. 183:348–357.
Abrass, C.K., 1986, Evaluation of sequential glomerular eluates from rats with Heymann nephritis, J. Immunol. 137:530–535.
Bagchus, W.M., Vos, J.T.W.M., Hoedemaeker, Ph. J., and Bakker, W.W., 1986, The specificity of nephritogenic antibodies. III. Binding of anti-FxlA antibodies in glomeruli is dependent on dual specificity, Clin. Exp. Immunol. 63:639–647.
Verroust, P., Ronco, P.M., and Chatelet, F., 1986, Monoclonal antibodies and identification of glomerular antigens, Kidney Int. 30:649–655.
Camussi, G., Noble, B., Van Liew, J., Brentjens, J.R., and Andress, G., 1986, Pathogenesis of passive Heymann glomerulonephritis: chlorpromazine inhibits antibody-mediated redistribution of cell surface antigens and prevents development of the disease, J. Immunol. 136:2127–2135.
Allegri, L., Brianti, E., Chatelet, F., Manara, G.C., Ronco, P., and Verroust, P., 1986, Polyvalent antigen-antibody interactions are required for the formation of electron-dense immune deposits in passive Heymann’s nephritis, Am. J. Pathol. 126:1–6.
Kerjaschki, D., Miettinen, A., and Farquhar, M.G., 1987, Initial events in the formation of immune deposits in passive Heymann nephritis, gp330-anti-gp330 immune complexes from in epithelial coated pits and rapidly become attached to the glomerular basement membrane, J. Exp. Med. 166:109–128.
Brown, D., McCluskey, R.T., and Ausiello, D.A., 1987, The cell biology of Heymann nephritis: A model of human membranous glomerulonephritis, Am. J. Kidney Dis. 5:74–76.
Pelletier, L., Galceran, M., Pasquier, R., Ronco, P., Verroust, P., Bariety, J., and Druet, P., 1987, Down modulation of Heymann’s nephritis by mercuric chloride, Kidney Int. 32:227–232.
Barabas, A.Z., Cornish, J., and Lannigan, R., 1986, Stimulation of circulating autoantibody levels in the rat with established progressive passive Heymann nephritis, Clin. Exp. Immunol. 65: 34–41.
Nakazawa, M., Emancipator, S.N., and Lamm, M.E., 1986, Proteolytic enzyme treatment reduces glomerular immune deposits and proteinuria in passive Heymann nephritis, J. Exp. Med. 164:1973–1987.
Furness, P.N. and Turner, D.R., 1987, An assessment of the influence of antigen dose in two new models of chronic serum sickness glomerulonephritis in the rat, Br. J. Exp. Path. 68:527–538.
Yamamoto, T., Miyazaki, S., Kawasaki, K., Yaoita, E., and Kihara, I., 1986, Rat bovine serum albumin (BSA) nephritis. VI. The influence of chemically altered antigen, Clin. Exp. Immunol. 65: 51–56.
Noble, B., Steward, M.W., Vladutiu, A., and Brentjens, J.R., 1987, Relationship of the quality and quantity of circulating anti-BSA antibodies to the severity of glomerulonephritis in rats with chronic serum sickness, Clin. Exp. Immunol. 67:277–282.
Koyama, A., Inage, H., Kobayashi, M., Narita, M., and Tojo, S., 1986, Effect of chemical cationization of antigen on glomerular localization of immune complexes in active models of serum sickness nephritis in rabbits, Immunology 58:529–534.
Chan, E.K.L., Boyd, N.D., Alexander, F., Barabas, A.Z., and Lanningan, R., 1986, Effect of cationic proteins on the glomerular deposition of anionic proteins and immune complexes, Nephron 43:93–104.
Camussi, G., Tetta, C., Meroni, M., Torri-Tarelli, L., Roffinello, C., Alberton, A., Deregibus, C., and Sessa, A., 1986, Localization of cationic proteins derived from platelets and polymorphonuclear neutrophils and local loss of anionic sites in glomeruli of rabbits with experimentally- induced acute serum sickness, Lab. Invest. 55:56–62.
Oite, T., Shimizu, F., Batsford, S.R., and Vogt, A., 1986, The effect of protamine sulfate on the course of immune complex glomerulonephritis in the rat, Clin. Exp. Immunol. 64:318–322.
Ward, D.M., Lee, S., and Wilson, C.B., 1986, Direct antigen binding to glomerular immune complex deposits, Kidney Int. 30:706–711.
Zanetti, M. and Wilson, C.B., 1986, A role for antiidiotypic antibodies in immunologically mediated nephritis, Am. J. Kidney Dis. 7:445–451.
Thomas, M.A.B. and Williams, D.G., 1987, Idiotypes and antiidiotypic antibodies in health and disease, Q.J. Med. 65:883–888.
Agodoa, L.Y.C. and Mannik, M., 1987, Removal of subepithelial immune complexes with excess unaltered or cationic antigen, Kidney Int. 32:13–18.
Raj, A.S., Tuscan, M., Shapiro, B., Glatfelter, A., Kunkel, R., and Wiggins, R.C., 1986, Amount of antibody is critical for immune complex displacement by charge competition from both rabbit glomeruli and anionic beads, Clin. Exp. Immunol. 64:629–637.
Nakazawa, M., Emancipator, S.N., and Lamm, M.E., 1986, Removal of glomerular immune complexes in passive serum sickness nephritis by treatment in vivo with proteolytic enzymes, Lab. Invest. 55:551–556.
Yamamoto, T., Yamamoto, K., Kawasaki, K., Yaoita, E., Shimizu, F., and Kihara, I., 1986, Immunoelectron microscopic demonstration of thy-1 antigen on the surfaces of mesangial cells in the rat glomerulus, Nephron 43:293–298.
Bagchus, W.M., Hoedemaeker, Ph. J., Rozing, J., and Bakker, W.W., 1986, Glomerulonephritis induced by monoclonal anti-thy 1.1 antibodies. A sequential histological and ulstrastructural study in the rat, Lab. Invest. 55:680–687.
Yamamoto, T. and Wilson, C.B., 1987, Complement dependence of antibody-induced mesangial cell injury in the rat, J. Immunol. 138:3758–3765.
Yamamoto, T. and Wilson, C.B., 1987, Quantitative and qualitative studies of antibody-induced mesangial cell damage in the rat, Kidney Int. 32:514–525.
Bagghus, W.M., Donga, J., Rozing, J., Hoedemaeker, Ph. J., and Bakker, W.W., 1986, The specificity of nephritogenic antibodies, Transplantation 41:739–745.
Mendrick, D.L. and Rennke, H.G., 1986, Immune deposits formed in situ by a monoclonal antibody recognizing a new intrinsic rat mesangial matrix antigen, J. Immunol. 137:1517–1526.
Matsuo, S., Fukatsu, A., Taub, M.L., Caldwell, P.R.B., Brentjens, J.R., and Andres, G., 1987, Glomerulonephritis induced in the rabbit by antiendothelial antibodies, J. Clin. Invest. 79: 1798–1811.
Koyama, A., Inage, H., Kobayashi, M., Ohta, Y., Narita, M., Tojo, S., and Cameron, J.S., 1986, Role of antigenic charge and antibody avidity on the glomerular immune complex localization in serum sickness mice, Clin. Exp. Immunol. 64:606–614.
Abrass, C.K. and Hori, M.T., 1987, Alterations in plasma clearance and tissue localization of model immune complexes in rats with streptozotocin-induced diabetes, Immunology 60:331–336.
Roccatello, D., Coppo, R., Martina, G., Rollino, C., Basolo, B., Frattasio, C., Fasano, M.E., Amoroso, A., Picciotto, G., Bajardi, P., Cordonnier, D., and Piccoli, G., 1987, Fc-receptor function of the mononuclear phagocyte system in glomerulonephritis secondary to some multisystem diseases, Am. J. Nephrol. 7:85–92.
Kanwar, Y.S., Caulin-Glaser, T., Gallo, G.R., and Lamm, M.E., 1986, Interaction of immune complexes with glomerular heparan sulfate-proteoglycans, Kidney Int. 30:842–851.
Hebert, L.A. and Cosio, F.G., 1987, The erythrocyte-immune complex-glomerulonephritis connection in man, Kidney Int. 31:877–885.
Kasinath, B.S., Maaba, M.R., Schwartz, M.M., and Lewis, E.J., 1986, Demonstration and characterization of C3 receptors on rat glomerular epithelial cells, Kidney Int. 30:852–861.
Cosio, F.G. and Bakaletz, A.P., 1986, Binding of human fibronectin to antigen-antibody complexes, J. Lab. Clin. Med. 107:453–458.
Cosio, F.G. and Bakaletz, A.P., 1987, Role of fibronectin on the clearance and tissue uptake of antigen and immune complexes in rats, J. Clin. Invest. 80:1270–1279.
Schena, F.P. and Pertosa, G., 1988, Fibronectin and the kidney, Nephron 48:177–182.
Meyer, P.A.R., 1987, The observation of immune complex formation and deposition in the eyes of living rabbits, Clin. Exp. Immunol. 69:166–178.
Chen, X-M., Tanaka, T., Kobayashi, Y., Shigematsu, H., and Okumura, K., 1987, Experimental glomerulonephritis induced by immune complexes of monoclonal antibodies produced by immunoglobulin class-switch variants, Lab. Invest. 57:665–672.
Abrahamson, D.R., 1986, Recent studies on the structure and pathology of basement membranes, J. Pathol. 149:257–278.
Timpl, R., 1986, Recent advances in the biochemistry of glomerular basement membrane, Kidney Int. 30:293–298.
Uitto, J., Murray, L.W., Blumberg, B., and Shamban, A., 1986, Biochemistry of collagen in disease, Ann. Intern. Med. 105:740–756.
Butkowski, R.J., Langeveld, J.P.M., Wieslander, J., Hamilton, J., and Hudson, B.G., 1987, Localization of the Goodpasture epitope to a novel chain of basement membrane collagen, J. Biol. Chem. 262:7874–7877.
Pusey, C.D., Dash, A., Kershaw, M.J., Morgan, A., Reilly, A., Rees, A.J., and Lockwood, C.M., 1987, A single autoantigen in Goodpasture’s syndrome identified by a monoclonal antibody to human glomerular basement membrane, Lab. Invest. 56:23–31.
Weber, M., Kohler, H., Manns, M., Baum, H-P., and Meyer Zum Buschenfelde, K-H, 1987, Identification of Goodpasture target antigens in basement membranes of human glomeruli, lung, and placenta, Clin. Exp. Immunol. 67:262–269.
Kefalides, N.A., 1987, The Goodpasture antigen and basement membranes: The search must go on, Lab. Invest. 56:1–3.
Bygren, P., Wieslander, J., and Heinegard, D., 1987, Glomerulonephritis induced in sheep by immunization with human glomerular basement membrane, Kidney Int. 31:25–31.
Wick, G., Von Der Mark, H., Dietrich, H., and Timpl, R., 1986, Globular domain of basement membrane collagen induces autoimmune pulmonary lesions in mice resembling human Goodpasture disease, Lab. Invest. 55:308–317.
Natori, Y. and Shibata, S., 1986, Comparison of nephritogenic glycopeptide, nephritogenoside, isolated from rat glomerular basement membranes with other basement membrane components, Connect. Tissue Res. 15:245–255.
Feintzeig, I.D., Abrahamson, D.R., Cybulsky, A.V., Dittmer, J.E., and Salant, D.I., 1986, Nephritogenic potential of sheep antibodies against glomerular basement membrane laminin in the rat, Lab. Invest. 55:531–541.
Makino, H., Gibbons, J.T., Reddy, M.K., and Kanwar, Y.S., 1986, Nephritogenicity of antibodies to proteoglycans of the glomerular basement membrane I, J. Clin. Invest. 77:142–156.
Makino, H., Lelongt, B., and Kanwar, Y.S., 1988, Nephritogenicity of proteoglycans II a model of immune complex nephritis, Kidney Int. 34:195–208.
Miettinen, A., Stow, J.L., Mentone, S., and Farquhar, M.G., 1986, Antibodies to basement membrane heparan sulfate proteoglycans bind to the laminae rarae of the glomerular basement membrane (GBM) and induce subepithelial GBM thickening, J. Exp. Med. 163:1064–1084.
Matsuo, S., Brentjens, J.R., Andres, G., Foidart, J-M., Martin, G.R., and Martinez-Hernandez, A., 1986, Distribution of basement membrane antigens in glomeruli of mice with autoimmune glomerulonephritis, Am. J. Pathol. 122:36–49.
Fukatsu, A., Matsuo, S., Killen, P.D., Martin, G.R., Andres, G.A., and Brentjens, J.R., 1988, The glomerular distribution of type IV collagen and laminin in human membranous glomerulonephritis, Hum. Pathol. 19:64–68.
Emancipator, S.N., 1986, Pathways of tissue injury initiated by humoral immune mechanisms, Lab. Invest. 54:475–478.
Hruby, Z., Lowry, R.P., Forbes, R.D.C., and Marghesco, D., 1986, Immune mechanisms and molecular mediators of glomerular injury in experimental nephritis: Summary of current results and continuing studies, Transplant. Proc. 18:664–666.
Boyce, N.W. and Holdsworth, S.R., 1986, Direct antiGBM antibody induced alterations in glomerular permselectivity, Kidney Int. 30:666–672.
Boyce, N.W. and Holdsworth, S.R., 1987, Intrarenal hemodynamic alterations induced by anti- GBM antibody, Kidney Int. 31:8–14.
Feucht, H.E., Jung, C.M., Gokel, M.J., Riethmuller, G., Zwirner, J., Brase, A., Held, E., and O’Neil, G.J., 1986, Detection of both isotypes of complement C4, C4A and C4B, in normal human glomeruli, Kidney Int. 30:932–936.
Koski, C.L., Sanders, M.E., Swoveland, P.T., Lawley, T.J., Shin, M.L., Frank, M.M., and Joiner, K.A., 1987, Activation of terminal components of complement in patients with Guillain- Barre syndrome and other demyelinating neuropathies, J. Clin. Invest. 80:1492–1497.
Sanders, M.E., Alexander, E.L., Koski, C.L., Frank, M.M., and Joiner, K.A., 1987, Detection of activated terminal complement (C5b-9) in cerebrospinal fluid from patients with central nervous system involvement of primary Sjogren’s syndrome or systemic lupus erythematosus, J. Immunol. 138:2095–2099.
Hinglais, N., Kazatchkine, M.D., Bhakdi, S., Appay, M-D., Mandet, C., Grossetete, J., and Bariety, J., 1986, Immunohistochemical study of the C5b-9 complex of complement in human kidneys, Kidney Int. 30:399–410.
Rus, H.G., Niculescu, F., Nanulescu, M., Cristea, A., and Florescu, P., 1986, Immunohistochemical detection of terminal C5b-9 complement complex in children with glomerular diseases,Clin. Exp. Immunol. 65:66–72.
Yoshioka, K., Takemura, T., Matsubara, K., Miyamoto, H., Akano, N., and Maki, S., 1987, Immunohistochemical studies of reflux nephropathy, Am. J. Pathol. 129:223–231.
Falk, R.J., Sisson, S.P., Dalmasso, A.P., Kim, Y,, Michael, A.F., and Vernier, R.L., 1987, Ultrastructural localization of the membrane attack complex of complement in human renal tissue, Am. J. Kidney Dis. 9:121–128.
Rauterberg, E.W., Lieberknecht, H-M., Wingen, A-M., and Ritz, E., 1987, Complement membrane attack (MAC) in idiopathic IgA-glomerulonephritis, Kidney Int. 31:820–829.
Cybulsky, A.V., Rennke, H.G., Feintzeig, I.D., and Salant, D.J., 1986, Complement-induced glomerular epithelial cell injury: The role of the membrane attack complex in rat membranous nephropathy, J. Clin. Invest. 77:1096–1104.
Cybulsky, A.V., Quigg, R.J., and Salant, D.J., 1986, The membrane attack complex in complement-mediated glomerular epithelial cell injury: Formation and stability of C5b-9 and C5b-7 in rat membranous nephropathy, J. Immunol. 137:1511–1516.
Camussi, G., Salvidio, G., Biesecker, G., Brentjens, J., and Andres, G., 1987, Heymann antibodies induced complement-dependent injury of rat glomerular visceral epithelial cells, J. Immunol. 139:2906–2914.
Betz, M., Seitz, M., and Hansch, G.M., 1987, Thromboxane B2 synthesis in human platelets induced by the late complement components C5b-9, Int. Arch. Allergy Appl. Immun. 82:313–316.
Hansch, G.M., Seitz, M., and Betz, M., 1987, Effect of the late complement components C5b-9 on human monocytes: Release of prostanoids, oxygen radicals and of a factor inducing cell proliferation, Int. Arch. Allergy Appl. Immun. 82:317–320.
Adler, S., Baker, P.J., Johnson, R.J., Ochi, R.F., Pritzl, P., and Couser, W.G., 1986, Complement membrane attack complex stimulates production of reactive oxygen metabolites by cultured rat mesangial cells, J. Clin. Invest. 77:762–767.
Lovett, D.H., Haensch, G-M., Goppelt, M., Resch, K., and Gemsa, D., 1987, Activation of glomerular mesangial cells by the terminal membrane attack complex of complement, J. Immunol. 138:2473–2480.
Hansch, G.M., Betz, M., Gunther, J., Rother, K.O., and Sterzel, B., 1988, The complement membrane attack complex stimulates the prostanoid production of cultured glomerular epithelial cells, Int. Arch. Allergy Appl. Immun. 85:87–93.
Thaiss, F., Batsford, S., Mihatsch, M.J., Heitz, P.U., Bitter-Suermann, D., and Vogt, A., 1986, Mediator systems in a passive model of in situ immune complex glomerulonephritis, Lab. Invest. 54:624–635.
Cook, H.T., Smith, J., and Cattell, V., 1987, Isolation and characterization of inflammatory leukocytes from glomeruli in an in situ model of glomerulonephritis in the rat, Am. J. Pathol. 126: 126–136.
Baud, L., and Ardailiou, R., 1986, Reactive oxygen species: production and role in the kidney, Am. J. Physiol. 251:F765–F776.
Canavese, C., Stratta, P., and Vercellone, A., 1987, Oxygen free radicals in nephrology, Int. J. Artificial Organs. 10:379–389.
Boyce, N.W. and Holdsworth, S.R., 1986, Hydroxyl radical mediation of immune renal injury by desferrioxamine, Kidney Int. 30:813–817.
Johnson, R.J., Couser, W.G., Chi, E.Y., Adler, S., and Klebanoff, S.J., 1987, New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxide-halide system, J. Clin. Invest. 79:1379–1387.
Johnson, R.J., Klebanoff, S.J., Ochi, R.F., Adler, S., Baker, P., Sparks, L., and Couser, W.G., 1987, Participation of the myeloperoxidase-H2O2-halide system in immune complex nephritis, Kidney Int. 32:342–349.
Shah, S.V., Baricos, W.H., and Basci, A., 1987, Degradation of human glomerular basement membrane by stimulated neutrophils, J. Clin. Invest. 79:25–31.
Johnson, R.J., Couser, W.G., Alpers, C.E., Vissers, M., Schulze, M., and Klebanoff, S.J., The human neutrophil serine proteinases, elastase and cathepsin G, can mediate glomerular injury in vivo, J. Exp. Med. 168:1169-1174.
Johnson, R.J., Alpers, C.E., Pritzl, P., Schulze, M., Baker, P., Pruchno, C., and Couser, W.G., 1988, Platelets mediate neutrophil-dependent immune complex nephritis in the rat, J. Clin. Invest. 82:1225–1235.
Nolasco, F.E.B., Cameron, J.S., Hartley, B., Coelho, A., Hildreth, G., and Reuben, R., 1987, Intraglomerular T cells and monocytes in nephritis: Study with monoclonal antibodies, Kidney Int. 31:1160–1166.
Hooke, D.H., Gee, D.C., and Atkins, R.C., 1987, Leukocyte analysis using monoclonal antibodies in human glomerulonephritis, Kidney Int. 31:964–972.
Boyce, N.W., Tipping, P.G., and Holdsworth, S.R., 1986, Lymphokine (MIF) production by glomerular T-lymphocytes in experimental glomerulonephritis, Kidney Int. 30:673–677.
Lovett, D.H. and Sterzel, R.B., 1986, Cell culture approaches to the analysis of glomerular inflammation, Kidney Int. 30:246–254.
Schlondorff, D., 1987, The glomerular mesangial cell: An expanding role for a specialized pericyte, Fed. Proc. 1:272–281.
Singhal, P.C., Scharschmidt, L.A., Gibbons, N., and Hays, R.M., 1986, Contraction and relaxation of cultured mesangial cells on a silicone rubber surface, Kidney Int. 30:862–873.
Simonson, M.S. and Dunn, M.J., 1986, Leukotriene C4 and D4 contract rat glomerular mesangial cells, Kidney Int. 30:524–531.
Lovett, D.H., Szamel, M., Ryan, J.L., Sterzel, R.B., Gemsa, D., and Resch, K., 1986, Interleukin 1 and the glomerular mesangium. I. Purification and characterization of a mesangium cell-derived autogrowth factor, J. Immunol. 136:3700–3705.
Castellot, J.J., Hoover, R.L., and Karnovsky, M.J., 1986, Glomerular endothelial cells secrete a heparin like inhibitor and a peptide stimulator of mesangial cell proliferation, Am. J. Pathol. 125: 493–500.
Werber, H.I., Emancipator, S.N., Tykocinski, M.L., and Sedor, J.R., 1987, The interleukin 1 gene is expressed by rat glomerular mesangial cells and is augmented in immune complex glomerulonephritis, J. Immunol. 138:3207–3212.
Lovett, D.H., Resch, K., and Gemsa, D., 1987, Interleukin I and the glomerular mesangium. II. Monokine stimulation of mesangial cell prostanoid secretion, Am. J. Pathol. 129:543–551.
Abboud, H.E., Poptic, E., and DiCorleto, P., 1987, Production of platelet-derived growth factorlike protein by rat mesangial cells in culture, J. Clin. Invest. 80:675–683.
Schlondorff, D., Goldwasser, P., Neuwirth, R., Satriano, J.A., and Clay, K.L., 1986, Production of platelet-activating factor in glomeruli and cultured glomerular mesangial cells, Am. J. Physiol. 250:F1123–F1127.
Lianos, E.A. and Zanglis, A., 1987, Biosynthesis and metabolism of l-O-alkyl-2-acetyl-snglycero- 3-phosphocholine in rat glomerular mesangial cells, J. Biol. Chem. 292:8990–8993.
Raugi, G.J. and Lovett, D.H., 1987, Thrombospondin secretion by cultured human glomerular mesangial cells, Am. J. Pathol. 129:364–372.
Sedor, J.R., Carey, S.W., and Emancipator, S.N., 1987, Immune complexes bind to cultured rat glomerular mesangial cells to stimulate superoxide release, J. Immunol. 138:3751–3757.
Lefkowith, J.B. and Schreiner, G., 1987, Essential fatty acid deficiency depletes rat glomeruli of resident macrophages and inhibits angiotensin II-induced eicosanoid synthesis, J. Clin. Invest. 80: 947–956.
Gurner, A.C., Smith, J., and Cattell, V., 1987, The origin of la antigen-expressing cells in the rat kidney, Am. J. Pathol. 127:342–347.
Seiler, M.W., Terrell, C.H., Finnegan, A., Sterzel, R.B., and Hoyer, J.R., 1986, Studies of glomerular mesangial uptake and processing of macromolecules. I. Effect of polyvinyl alcoholinduced macrophages on uptake of iron dextran, Lab. Invest. 54:616–623.
Kimura, M., Nagase, M., Hishida, A., and Honda, N., 1987, Intramesangial passage of mononuclear phagocytes in murine lupus glomerulonephritis, Am. J. Pathol. 127:149–156.
Tipping, P.G., Worthington, L.A., and Holdsworth, S.R., 1987, Quantitation and characterization of glomerular procoagulant activity in experimental glomerulonephritis, Lab. Invest. 56:155–159.
Tipping, P.G. and Holdsworth, S.R., 1986, The participation of macrophages, glomerular procoagulant activity, and factor VIII in glomerular fibrin deposition. Studies on anti-GBM antibody- induced glomerulonephritis in rabbits, Am. J. Pathol. 124:10–17.
Cole, E.H., Sweet, J., and Levy, G.A., 1986, Expression of macrophage procoagulant activity in murine systemic lupus erythematosus, J. Clin. Invest. 78:887–893.
Kanfer, A., DeProst, D., Guettier, C., Nochy, D., Le Floch, V., Hinglais, N., and Druet, P., 1987, Enhanced glomerular procoagulant activity and fibrin deposition in rats with mercuric chloride-induced autoimmune nephritis, Lab. Invest. 57:138–143.
Wiggins, R.C., Glatfelter, A., Kshirsagar, B., and Brukman, J., 1986, Procoagulant activity in normal human urine associated with subcellular particles, Kidney Int. 29:591–597.
Wiggins, R., Glatfelter, A., Kshirsager, B., and Beals, T., 1987, Lipid microvesicles and their association with procoagulant activity in urine and glomeruli of rabbits with nephrotoxic nephritis, Lab. Invest. 56:264–272.
Takemura, T., Yoshioka, K., Akano, N., Miyamoto, H., Matsumoto, K., and Maki, S., 1987, Glomerular deposition of cross-linked fibrin in human kidney diseases, Kidney Int. 32:102–111.
Tipping, P.G., Dowling, J.P., and Holdsworth, S.R., 1988, Glomerular procoagulant activity in human proliferative glomerulonephritis, J. Clin. Invest. 81:119–125.
Tipping, P.G., Thomson, N.M., and Holdsworth, S.R., 1986, A comparison of fibrinolytic and defibrinating agents in established experimental glomerulonephritis, Br. J. Exp. Pathol. 67:481–491.
Wardle, E.N., 1986, Anticoagulation in renal diseases: 20 years on and what is the outcome? Nephron 44:81–84.
Capron, A., Joseph, M., Ameisen, J.C., Capron, M., Pancre, V., and Auriault, C., 1987, Platelets as effectors in immune and hypersensitivity reactions, Int. Arch. Allergy Appl. Immun. 82:307–312.
Nath, K.A., 1987, Platelet participation in renal diseases, Kidney 20:1–6.
Camussi, G., Pawlowski, I., Saunders, R., Brentjens, J., and Andres, G., 1987, Receptor antagonist of platelet activating factor inhibits inflammatory injury induced by in situ formation of immune complexes in renal glomeruli and in the skin, J. Lab. Clin. Med. 110:196–206.
Bertani, T., Livio, M., Macconi, D., Morigi, M., Bisogno, G., Patrono, C., and Remuzzi, G., 1987, Platelet activating factor (PAF) as a mediator of injury in nephrotoxic nephritis, Kidney Int. 31:1248–1256.
Schlondorff, D., Detlef, S., and Neuwirth, R., 1986, Platelet-activating factor and the kidney, Am. J. Physiol. 251:F1–F11.
Stahl, R.A.K. and Thaiss, F., 1987, Eicosanoids: Biosynthesis and function in the glomerulus, Renal Physiol 10:1–13.
Rahman, M.A., Stork, J.E., and Dunn, M.J., 1987, The roles of eicosanoids in experimental glomerulonephritis, Kidney Int. 32:S40–S48.
Ardaillou, R., Baud, L., and Sraer, J., 1987, Role of arachidonic acid metabolites and reactive oxygen species in glomerular immune-inflammatory process, Springer Semin. Immunopathol. 9: 371–385.
Stahl, R.A.K., Adler, S., Baker, P.J., Chen, Y-P., Pritzl, P.M., and Couser, W.G., 1987, Enhanced glomerular prostaglandin formation in experimental membranous nephropathy, Kidney Int. 31:1126–1131.
Pugliese, F., Singh, A.K., Kasinath, B.S., Kreisberg, J.I., and Lewis, E.J., 1987, Glomerular epithelial cell, polyanion neutralization is associated with enhanced prostanoid production, Kidney Int. 32:57–61.
Zoja, C., Benigni, A., Verroust, P., Ronco, P., Bertani, T., and Remuzzi, G., 1987, Indomethacin reduces proteinuria in passive Heymann nephritis in rats, Kidney Int. 31:1335–1343.
Shinkai, Y. and Cameron, S., 1987, Rabbit nephrotoxic nephritis: Effect of a thromboxane synthesis inhibitor on evolution and prostaglandin excretion, Nephron 47:211–219.
Cybulsky, A.V., Lieberthal, W., Quigg, R.J., Rennke, H.G., and Salant, D.J., 1987, A role for thromboxane in complement-mediated glomerular injury, Am. J. Pathol. 128:45–51.
Ulich, T.R., Meline, J.A., Ni, R-X., Keys, M., and Wu, C.H., 1987, Stable analogs of prostaglandins Et and F2a ameliorate the proteinuria of aminonucleoside-of-puromycin nephrosis in Lewis rats, Am. J. Pathol. 129:133–139.
Levey, A.S., Lau, J., Pauker, S.G., and Kassirer, J.P., 1987, Idiopathic nephrotic syndrome, puncturing the biopsy myth, Ann. Intern. Med. 107:697–713.
Mallick, N.P., Short, C.D., and Hunt, L.P.,1987, How far since Ellis? The Manchester study of glomerular disease, Nephron 46:113–124.
Katafuchi, R., Takebayashi, S., Taguhi, T., and Harada, T., 1987, Structural-function correlations in serial biopsies from patients with glomerulonephritis,. Clin. Nephrol. 28:169–173.
Tiebosch, A., Wolters, J., Frederik, P., VanDerWiel, T., Zeppenfeldt, E., and van Brenda Vriesman, P., 1987, Epidemiology of idiopathic glomerular disease: A prospective study, Kidney Int. 32:112–116.
Date, A., Raghavan, R., John, T.J., Richard, J., Kirubakaran, M.G., and Shastry, J.C.M., 1987, Renal disease in adult indians: A clinicopathological study of 2827 patients, Q.J. Med. 64: 729–737.
Lockwood, C.M., 1986, New advances in understanding the treatment of glomerulonephritis, Clin. Nephrol. 26:S76–S80.
Glassock, R.J., 1987, Clinical aspects of glomerular disease, Am. J. Kidney Dis. 10:181–185.
De Santo, N.G., Nuzzi, F., Capodicasa, G., Lama, G., Caputo, G., Rosati, P., and Giordano, C., 1987, Phase contrast microscopy of the urine sediment for the diagnosis of glomerular and nonglomerular bleeding-data in children and adults with normal creatrinine clearance, Nephron 45:35– 39.
Stapleton, F.B., 1987, Morphology of urinary red blood cells: A simple guide in localizing the site of hematuria, Pediatr. Clin. North Am. 34:561–569.
Raman, G.V., Pead, L., Lee, H.A., and Maskell, R., 1986, A blind controlled trial of phasecontrast microscopy by two observers for evaluating the source of haematuria, Nephron 44:304– 308.
Bergroth, V., Konnttinen, Y., Nordstrom, D., and Laasonen, L., 1987, Loin pain and haematuria syndrome: Possible association with intrarenal arterial spasms, Br. Med. J. 294:1657.
Levy, M., 1986, Infections and glomerular disease, Clin. Immun. Allerg. 6:405–435.
Jones, J.M.B., and Davison, A.M., 1986, Persistent infection as a cause of renal disease in patients submitted to renal biopsy: A report from the glomerulonephritis registry of the United Kingdom MRC, Q.J. Med. 58:123–132.
Berrios, X., Quesney, F., Morales, A., Blazquez, J., Lagomarsino, E., and Bisno, A.L., 1986, Acute rheumatic fever and poststreptococcal glomerulonephritis in an open population: Comparative studies of epidemiology and bacteriology, J. Lab. Clin. Med. 108:535–542.
Chugh, K.S., Malhotra, H.S., Sakhuja, V., Bhusnurmath, S., Singhal, P.C., Unni, V.N., Singh, N., Pirzada, R., and Kapoor, M.M., 1987, Progression to ehd stage renal disease in poststreptococcal glomerulonephritis (PSGN)-Chandigarh study, Int. J. Art. Organs 10:189–194.
Leung, D.T.Y., Tseng, R.Y.M., Go, S.H., French, G.L., and Lam, C.W.K., 1987, Poststreptococcal glomerulonephritis in Hong Kong, Arch. Dis. Childhood 62:1075–1076.
Williams, W., 1987, Poststreptococcal glomerulonephritis: How important is it as a cause of chronic renal diseases, Transplant. Proc. 14:97–100.
Fairley, C., Mathews, D.C., and Becker, G.J., 1987, Rapid development of diffuse crescents in post-streptococcal glomerulonephritis, Clin. Nephrol. 28:256–260.
Melby, P.C., Musick, W.D., Luger, A.M., and Khanna, R., 1987, Poststreptococcal glomerulonephritis in the elderly, Am. J. Nephrol. 7:235–240.
Vogl, W., Renke, M., Mayer-Eichberger, D., Schmitt, H., and Bohle, A., 1986, Long-term prognosis for endocapillary glomerulonephritis of poststreptococcal type in children and adults, Nephron 44:58–65.
Sorger, K., Gessler, M., Hubner, F.K., Kohler, H., Olbing, H., Schulz, W., Thoenes, G.H., and Thoenes, W., 1987, Follow-up studies of three subtypes of acute postinfections glomerulonephritis ascertained by renal biopsy, Clin. Nephrol. 27:111–124.
Lange, C.F., Weber, M., and Nayyar, R.P., 1986, Age-effects on the reactivity of antistreptococcal cell membrane antisera to murine glomerular basement membrane, Renal Physiol. 9:148–159.
Sesso, R.C.C., Ramos, O.L., and Pereira, A.B., 1986, Detection of IgG-rheumatoid factor in sera of patients with acute poststreptococcal glomerulonephritis and its relationship with circulating immunecomplexes, Clin. Nephrol. 26:55–60.
Scully, R.E., Mark, E.J., McNeely, W.F., and McNeely, B.U., 1987, Case records of the Massachusetts General Hospital: Case 26-1987, N. Engl. J. Med. 316:1642–1651.
Craddock, C.F., Richards, N.P., Powell, R.J., and Morgan, A.G., 1987, Novel C3 nephtritic factor activity in the glomerulonephritis of staphylococcal endocarditis, Q.J. Med. 65:895–898.
Sobh, M.A., Moustafa, F.E., El-Housseini, F., Basta, M.T., Deelder, A.M., and Ghoniem, M.A., 1987, Schistosomal specific nephropathy leading to end-stage renal failure, Kidney Int. 31: 1006–1011.
Martinelli, R., Perreijra, L.J., and Rocha, H., 1987, The influence of anti-parasitic therapy on the course of the glomerulopathy associated with Schistosomiasis mansoni, Clin. Nephrol. 27:229–232.
Herrara, G.A., Alexander, R.W., Cooley, C.F., Luke, R.G., Kelly, D.R., Curtis, J.J., and Gockerman, J.P., 1986, Cytomegalovirus glomerulopathy: A controversial lesion, Kidney Int. 29: 725–733.
Magil, A.B. and Ballon, H.S., 1987, IgA nephropathy, Nephron 47:246–252.
Bene, M.C. and Faure, G., 1987, IgA nephropathy, Springer Semin. Immunopathol. 9:387–398.
Bennett, W.M., Nicholls, K., and Kincaid-Smith, P., 1987, Clinicopathological associations in mesangial IgA nephropathy, Am. J. Nephrol. 7:166–167.
Boyce, N.W., Hodsworth, S.R., Thompson, N.M., and Atkins, R.C., 1986, Clinicopathological associations in mesangial IgA nephropathy, Am. J. Nephrol. 6:246–252.
Clarkson, A.R., Woodroffe, A.J., Aarons, I., Hiki, Y., and Hale, G., 1987, IgA Nephropathy, Annu. Rev. Med. 38:157-168.
D’Amico, G., 1987, The commonest glomerulonephritis in the world: IgA nephropathy, Q.J. Med. 64:709–727.
D’Amico, G., Minetti, L., Ponticelli, C., Fellin, G., Ferrario, F., Barbiano Di Belgioioso, G., Imbasciati, E., Ragni, A., Bertoli, S., Fogazzi, G., and Duca, G., 1986, Prognostic indicators in idiopathic IgA mesangial nephropathy, Q.J. Med. 59:363–378.
Lee, H.S., Koh, H.I., Lee, H.B., and Park, H.C., 1987, IgA nephropathy in Korea: A morphological and clinical study, Clin. Nephrol. 27:131–140.
Yoshikawa, N., Ito, H., Yoshiya, K., Nakahara, C., Yoshiara, S., Hasegawa, O., Matsuyama, S., and Matsuo, T., 1987, Henoch-Schoenlein nephritis and IgA nephropathy in children: A comparison of clinical course, Clin. Nephrol. 27:233–237.
Thorner, P.S., Farine, M., Arbus, G.S., Poucell, S., and Baumal, R., 1986, IgA nephropathy: Henoch-Schönlein purpura and Berger’s disease in one patient, Int. J. Pediatr. Nephrol. 7:131– 136.
Yoshikawa, N., Ito, H., Yoshiara, S., Nakahara, C., Yoshiya, K., Hasegawa, O., and Matsuo, T., 1987, Clinical course of immunoglobulin A nephropathy in children, J. Pediatr. 110:555–560.
Kusumoto, Y., Takebayashi, S., Taguchi, T., Harada, T., and Naito, S., 1987, Long-term prognosis and prognostic indices of IgA nephropathy in juvenile and in adult Japanese, Clin. Nephrol. 28:118–124.
Yoshikawa, N., Ijima, K., Maehara, K., Yoshiara, S., Yoshiya, K., Matsua, T., and Okada, S., 1987, Mesangial changes in IgA nephropathy in children, Kidney Int. 32:585–589.
Rambausek, M., Waldherr, R., Rauterberg, W., Andrassy, K., and Ritz, E., 1987, Mesangial IgA nephropathy and idiopathic nephrotic syndrome, Nephron 47:190–193.
Yoshimura, M., Kida, H., Abe, T., Takeda, S., Katagiri, M., and Hattori, N., 1987, Significance of IgA deposits on the glomerular capillary walls in IgA nephropathy, Am. J. Kidney Dis. 9:404–409.
Andreoli, S., Yum, M.N., and Bergstein, J.M., 1986, IgA nephropathy in children: significance of glomerular basement membrane deposition of IgA, Am. J. Nephrol. 6:28–33.
Jennette, J.C., Newman, J., and Diaz-Buxo, J.A., 1987, Overlapping IgA and membranous nephropathy, Am. J. Clin. Pathol. 88:74–78.
Perez-Fontan, M., Miguel, J.L., Picazo, M.L., Martinez-Ara, J., Selgas, R., and Sicilia, L.S., 1986, Idiopathic IgA nephropathy presenting as malignant hypertension, Am. J. Nephrol. 6:482–486.
Lubias, R., Botley, A., Darnell, A., Montoliu, J., and Revert, L., 1987, Malignant or accelerated hypertension in IgA nephropathy, Clin. Nephrol. 27:1–7.
Kincaid-Smith, P. and Fairley, K.F., 1987, Renal disease in pregnancy, three controversial areas: Mesangial IgA nephropathy, focal glomerular sclerosis (focal and segmental hyalinosis and sclerosis), and reflux nephropathy, Am. J. Kidney Dis. 9:328–333.
Rifai, A., 1987, Experimental models for IgA-associated nephritis, Kidney Int. 31:1–7.
Yoshikawa, N., Yoshiara, S., Yoshiya, K., and Matsua, T., 1986, Lysis of the glomerular basement membrane in children with IgA nephropathy and Henoch-Schonlein nephritis, J. Pathol. 150:119–126.
Terasaki, T., Sano, M., Narita, M., and Tojo, S., 1986, Ultrastructural study of gaps of the glomerular basement membrane in IgA nephropathy, Am. J. Nephrol. 6:443–449.
Wyatt, R.J., Rivas, M.L., Julian, B.A., Quiggins, P.A., Woodford, S.Y., McMorrow, R.G., and Baehler, R.W., 1987, Regionalization in hereditary IgA nephropathy, Am. J. Hum. Genet. 41:36–50.
Levy, M., 1987, Do genetic factors play a role in Berger’s disease? Pediatr. Nephrol. 1:447–454.
Welch, T.R., Berry, A., and Beischel, L.S., 1987, C4 isotype deficiency in IgA nephropathy, Pediatr. Nephrol. 1:136–139.
Naito, S., Kohara, M., and Arakawa, K., 1987, Association of class II antigens of HLA with primary glomerulopathies, Nephron 45:111–114.
Hale, G.M., Mcintosh, S.L., Hiki, Y., Clarkson, A.R., and Woodroffe, A.J., 1986, Evidence for IgA-specific B cell hyperactivity in patients with IgA nephropathy, Kidney Int. 29:718– 724.
Feehally, J., Beattie, T.J., Brenchley, P.E.C., Coupes, B.M., Mallick, N.P., and Postlethwaite, R.J., 1986, Sequential study of the IgA system in relapsing IgA nephropathy, Kidney Int. 30:924–931.
Schena, F.P., Mastrolitta, G., Fracasso, A.R., Pastore, A., and Ladisa, N., 1986, Increased immunoglobulin-secreting cells in the blood of patients with active idiopathic IgA nephrology, Clin. Nephrol. 26:163–168.
Lai, K.N., Lai, F.M., Chui, S.H., Chan, Y.M., Tsao, G.S.W., Leung, K.N., and Lam, C.W.K., 1987, Studies of lymphocyte subpopulations and immunoglobulin production in IgA nephropathy, Clin. Nephrol. 28:281–287.
Leinikki, P.O., Mustonen, J., and Pasternack, A., 1987, Immune response to oral polio vaccine in patients with IgA glomerulonephritis, Clin. Exp. Immunol. 68:33–38.
Russell, M.W., Mestecky, J., Julian, B.A., and Galla, J.H., 1986, IgA-associated renal diseases: Antibodies to environmental antigens in sera and deposition of immunoglobulins and antigens in glomeruli, J. Clin. Immunol. 6:74–86.
Coppo, R., Basolo, B., Rollino, C., Roccatello, D., Martina, G., Amore, A., Bongiorno, G., and Piccoli, G., 1986, Mediterranean diet and primary IgA nephropathy, Clin. Nephrol. 26:72–82.
Lozano, L., Garcia-Hoyo, R., and Egido, J., 1987, IgA nephropathy: Association of a history of macroscopic hematuria episodes with increased production of polymeric IgA, Nephron 45:98–103.
Davin, J.C., Foidart, J.B., and Mahieu, P.R., 1987, Relation between biological IgA abnormalities and messangial IgA deposits in isolated hematuria in childhood, Clin. Nephrol. 28:73–80.
Hernando, P., Edigo, J., de Nicolas, R., and Sancho, J., 1986, Clinical significance of polymeric and monomelic IgA complexes in patients with IgA nephropathy, Am. J. Kidney Dis. 8:410–416.
Yagame, M., Miura, T.M., Tanigaki, T., Suga, T., Nomoto, Y., and Sakai, H., 1987, Detection of IgA-class circulating immune complexes (CIC) in sera from patients with IgA nephropathy using a solid-phase anti-C3 Facb enzyme immunoassay (EIA), Clin. Exp. Immunol. 67:270–276.
Julian, B.A., Czerkinsky, C., Russell, M.W., Galla, J.H., Koopman, W.J., Mestecky, J., Moldoveanu, Z., and Jackson, S., 1987, Striking elevation of serum IgA, IgA-containing immune complexes, and IgA reheumatoid factor in clinically silent dermatitis herpetiformis, Am. J. Kidney Dis. 10:378–384.
Czerkinsky, C., Koopman, W., Jackson, S., Collins, J., Crago, S., Schrohenloher, R.E., Julian, B.A., Galla, J.H., and Mestecky, J., 1986, Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies, J. Clin. Invest. 77:1931–1938.
Sinico, R.A., Fornasieri, A., Oreni, N., Benuzzi, S., and D’Amico, G., 1986, Polymeric IgA rheumatoid factor in idiopathic IgA mesangial nephropathy (Berger’s disease), J. Immunol. 137: 536–541.
Fornasieri, A., Sinico, R.A., Maldifassi, P., Bernasconi, P., Vegni, M., and D’Amico, G., 1987, IgA-Antigliadin antibodies in IgA mesangial nephropathy (Berger’s disease), Br. Med. J. 295:78– 80.
Yap, H.K., Sakai, R.S., Woo, K.T., Lim, C.H., and Jordan, S.C., 1987, Detection of bovine serum albumin in the circulating IgA immune complexes of patients with IgA nephropathy, Clin. Immunol. Immunopathol. 43:395–402.
Gonzalez-Cabrero, J., Egido, J., Sancho, J., and Moldenhauer, F., 1987, Presence of shared idiotypes in serum and immune complexes in patients with IgA nephropathy, Clin. Exp. Immunol. 68:694–702.
Nagy, J., Ambrus, M., Paal, M., Trinn, C., and Burger, T., 1987, Cryoglobulinaemia and cryofibrinogenaemia in IgA nephropathy: A follow-up study, Nephron 46:337–342.
Tomino, Y., Yagame, M., Omata, F., Nomoto, Y., and Sakai, H., 1987, A case of IgA nephropathy associated with adeno- and herpes simplex viruses, Nephron 47:258–261.
Nomoto, Y., Suga, T., Miura, M., Nomoto, H., Tomino, Y., and Sakai, H., 1986, Characterization of an acidic nuclear protein recognized by autoantibodies in sera from patients with IgA nephropathy, Clin. Exp. Immunol. 65:513–519.
Emancipator, S.E., Ovary, Z., and Lamm, M.E., 1987, The role of mesangial complement in the hematuria of experimental IgA nephropathy, Lab. Invest. 57:269–276.
Rifai, A., Chen, A., and Imai, H., 1987, Complement activation in experimental IgA nephropathy: An antigen-mediated process, Kidney Int. 32:838–844.
Tomino, Y., Yagame, M., Eguchi, K., Nomato, Y., and Sakai, H., 1987, Immunofluorescent studies on S-protein in glomeruli from patients with IgA nephropathy, Am. J. Pathol. 129:402–406.
Chan, M.K., Kwan, S.Y.L., Chan, K.W., and Yeung, C.K., 1987, Controlled trial of antiplatelet agents in mesangial IgA glomerulonephritis, Am. J. Kidney Dis. 4:417–421.
Belovexhdov, N. and Robeva, R., 1987, Clinical and therapeutic studies in mesangial immunoglobulin A glomerulonephritis, Int. Urol. Nephrol. 19:341–345.
Lai, K.N., Lai, F.M., and Chan, K.W., 1986, Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: A long-term controlled trial, Clin. Nephrol. 26:174–180.
Woo, K.T., Edmondson, R.P.S., Yap, H.K., Wu, A.Y.T., Chiang, G.S.C., Lee, E.J.C., Pwee, H.S., and Lim, C.H., 1987, Effects of triple therapy on the progression of mesangial proliferative glomerulonephritis, Clin. Nephrol. 27:56–64.
Woo, K.T., et al. , 1987, Letter to the editor, Clin. Nephrol. 27:304–306.
Lai, K.N., Lai, F.M., Li, P.K.T., and Vallance-Owen, J., 1987, Cyclosporin treatment of IgA nephropathy: A short term controlled trial, Br. Med. J. 295:1165–1168.
Kobayashi, Y., Fujii, K., Hiki, Y., and Tateno, S., 1986, Steroid therapy in IgA nephropathy: A prospective pilot study in moderate proteinuric cases, Q.J. Med. 61:935–943.
Lai, K.N., Lai, F.M., Leung, A.C.T., Ho, C.P., and Vallance-Owen, J., 1987, Plasma exchange in patients with rapidly progressive idiopathic IgA nephropathy: A report of two cases and review of literature, Am. J. Kidney Dis. 10:66–70.
Bachman, U., Biaza, C., Amend, W., Feduska, N., Melzer, J., Salvatierra, O., and Vincenti, F., 1986, The clinical course of IgA-nephropathy and Henoch-Schonlein purpura following renal transplantation, Transplantation 42:511–515.
Helin, H., Korpela, M., Mustonen, J., and Pasternack, A., 1986, Mild mesangial glomerulopathy— A frequent finding in rheumatoid arthritis patients with hematuria or proteinuria, Nephron 42:224–230.
Shu, K.H., Lian, J.D., Yang, Y.F., Lu, Y.S., Wang, J.Y., Lan, J.L., and Chou, G., 1986, Glomerulonephritis in ankylosing spondylitis, Clin. Nephrol. 25:169–174.
Newell, G.C., 1987, Cirrhotic glomerulonephritis: Incidence, morphology, clinical features, and pathogenesis, Am. J. Kidney Dis. 9:183–190.
Kawaguchi, K., and Koike, M., 1986, Glomerular lesions associated with liver cirrhosis: An immunohistochemical and clinicopathologic analysis, Hum. Pathol. 17:1137–1143.
Praga, M., Costa, J.R., Shandas, G.J., Martinez, M.A., Miranda, B., andRodicio, J.L., 1987, Acute renal failure in cirrhosis associated with macroscopic hematuria of glomerular origin, Arch. Intern. Med. 147:173–174.
Couser, W.G., 1986, Chapter 100, Glomerular diseases, in: Textbook of Medicine. A Systematic Approach, 2nd ed. (J. Stein et al. eds.), Little Brown, Boston, pp. 834–861.
Couser, W.G., 1988, Rapidly progressive glomerulonephritis. Classification and treatment, Am. J. Kidney Dis. 11:449–464 (In-depth Review.)
Salant, D.J., 1987, Immunopathogenesis of crescentic glomerulonephritis and lung purpura, Kidney Int. 32:408–425.
Savage, C.O., Pusey, C.D., Bowman, C., Rees, A.J., and Lockwood, C.M., 1986, Antiglomerular basement membrane antibody mediated disease in the British Isles 1980-4, Br. Med. J. 292:301–304.
Balow, J.E., 1986, Plasmapheresis: Development and application in treatment of renal disorders, Artificial Organs 101:324–330.
Jones, J.V., 1986, Response to apheresis: Problems of assessment in immune disease, Clin. Nephrol. 26:S70–S75.
Vangelista, A., Frasca, G.M., and Bonomini, V., 1986, Parameters for indication of plasmapheresis and the interpretation of results, Clin. Nephrol. 26:S64–S69.
Gajdos, P., Pourrat, J., Elkharrat, D., and Terre, C., 1987, National register for plasma exchange— The French Society for Hemapheresis. Results for 1985, Plasma Ther. Technol. 8:137=141.
Nilssen, D.E., Talseth, T., and Brodwall, E.K., 1986, The many faces of Goodpasture’s syndrome, Acta. Med. Scand. 220:489–491.
Mehler, P.S., Brunvand, M.W., Hutt, M.P., and Anderson, R.J., 1987, Chronic recurrent Goodpasture’s syndrome, Am. J. Med. 82:833–835.
Teruel, J.L., Liano, F., Mampaso, F., Moreno, J., Serrano, A., Quereda, C., and Ortuno, J., 1987, Allograft antiglomerular basement membrane glomerulonephritis in a patient with Alport’s syndrome, Nephron 46:43–44.
Croker, B.P., Lee, T., and Gunnells, J.C., 1987, Clinical and pathologic features of polyarteritis nodosa and its renal-limited variant: Primary crescentic and necrotizing glomerulonephritis, Hum. Pathol. 18:39–44.
Furlong, T.J., Ibels, L.S., and Eckstein, R.P., 1987, The clinical spectrum of necrotizing glomerulonephritis, Medicine 66:192–201.
Adu, D., Howie, A.J., Scott, D.G.I., Bacon, P.A., McGonigle, R.J.S., and Michael, J., 1987, Polyarteritis and the kidney, Q.J. Med. 62:221–237.
Velosa, J.A., 1987, Idiopathic crescentic glomerulonephritis or systemic vasculitis? Mayo Clin. Proc. 62:145–147.
Savage, C.O., Jones, S., Winearls, C.G., Marshall, P.D., and Lockwood, C.M., 1987, Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis, Lancet 20:1389–1393.
Falk, R.J. and Jennette, J.C., 1988, Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis, N. Engl. J. Med. 318:1651–1657.
Baldwin, D.S., Neugarten, J., Feiner, H.D., Gluck, M., and Spinowitz, B., 1987, The existence of a protracted course in crescentic glomerulonephritis, Kidney Int. 31:790–794.
Belghiti, D., Levy, Y., Rifle, G., Ottavioli, J., Rickelynck, J., Wolf, C., Chalopin, J., and Sobel, A., 1987, Relapses of idiopathic diffuse crescentic glomerulonephritis without immune deposits: Report of 6 cases, Am. J. Nephrol. 7:22–27.
Boyce, N.W. and Holdsworth, S.R., 1986, Idiopathic Goodpasture’s syndrome, Nephron 44:22–25.
Bolton, W.K., Innes, D.J., Sturgill, B.C., and Kaiser, D.L., 1987, T cells and macrophages in rapidly progressive glomerulonephritis: Clinicopathologic correlations, Kidney Int. 32:869–876.
Yoshioka, K., Takemura, T., Akano, N., Miyamoto, H., Iseki, T., and Maki, S., 1987, Cellular and non-cellular compositions of crescents in human glomerulonephritis, Kidney Int. 32:284–291.
Schwab, S.J., Christensen, R.L., Dougherty, K., and Klahr, S., 1987, Quantitation of proteinuria by the use of protein-to-creatinine ratios in single urine samples, Arch. Intern. Med. 147: 943–944.
Houser, M.T., Jahn, M.F., Kobayashi, A., and Walburn, J., 1986, Assessment of urinary protein excretion in the adolescent: Effect of body position and exercise, J. Pediatr. 109:556–561.
Nathan, D.M., Rosenbaum, C., and Protasowicki, V.D., 1987, Single-void urine samples can be used to estimate quantitative microalbuminuria, Diabetes Care 10:414–418.
Furness, P.N., Turner, D.R., and Cotton, R.E., 1986, Basement membrane charge in human glomerular disease, J. Pathol. 150:267–278.
Kerjaschki, D., Poczewski, H., Dekan, G., Horvat, R., Balzar, E., Kraft, N., and Atkins, R.C., 1986, Identification of a major sialoprotein in the glycocalyx of human visceral glomerular epithelial cells, J. Clin. Invest. 78:1142–1149.
Horvat, R., Hovarka, A., Dekan, G., Poczewski, H., and Kerjaschki, D., 1986, Endothelial cell membranes contain podocalzxin—The major sialoprotein of visceral glomerular epithelial cells, J. Cell Biol. 102:484–491.
Bertolatus, J.A. and Hunsicker, L.G., 1987, Polycation binding to glomerular basement membrane: Effect of biochemical modification, Lab. Invest. 56:170–179.
Lelongt, B., Makino, H., and Kanwar, Y.S., 1987, Status of glomerular proteoglycans in aminonucleoside nephrosis, Kidney Int. 31:1299–1310.
Batsford, S.R., Rohbach, R., and Vogt, A., 1987, Size reduction in the glomerular capillary wall: Importance of lamina densa, Kidney Int. 31:710–717.
Bertolatus, J.A., Abuyousef, M., and Hunsicker, L.G., 1987, Glomerular sieving of high molecular weight proteins in proteinuric rats, Kidney Int. 31:1257–1266.
Shemesh, O., Deen, W.M., Brenner, B.M., McNeely, E., and Myers, B.D., 1986, Effect of colloid volume expansion on glomerular barrier size-selectivity in humans, Kidney Int. 29:916–923.
Weening, J.J., Guldener, C.V., Daha, M.R., Klar, N., Van Der Wal, A., and Prins, F.A., 1987, The pathophysiology of protein-overload proteinuria, Am. J. Pathol. 129:64–73.
Schwartz, M.M., Bidani, A.K., and Lewis, E.J., 1986, Glomerular epithelial cell structure and function in chronic proteinuria induced by homologous protein-load, Lab. Invest. 55:673–679.
Messina, A., Davies, D.J., Dillane, P.C., and Ryan, G.B., 1987, Glomerular epithelial abnormalities associated with the onset of proteinuria in aminonucleoside nephrosis, Am. J. Pathol. 126:220–229.
Cameron, J.S., 1987, The nephrotic syndrome and its complications, Am. J. Kidney Dis. 10:157–171.
Fadnes, H.O., Pape, J.F., and Sundsfjord, J.A., 1986, A study on oedema mechanisms in nephrotic syndrome, Scand. J. Clin. Lab. Invest. 46:533–538.
Shapiro, M.D., Nicholls, K.M., Groves, B.M., and Schrier, R.W., 1986, Role of glomerular filtration rate in the impaired sodium and water excretion of patients with the nephrotic syndrome, Am. J. Kidney Dis. 8:81–87.
Koomans, H.A., Boer, W.H., and Mees, E.J.D., 1987, Renal function during recovery from minimal lesions nephrotic syndrome, Nephron 47:173–178.
Tulassay, T., Rascher, W., Lang, R.E., Seyberth, H.W., and Scharer, K., 1987, Atrial natriuretic peptide and other vasocative hormones in nephrotic syndrome, Kidney Int. 31:1391–1395.
Kaysen, G.A., Gambertoglio, J., Felts, J., and Hutchison, F.N., 1987, Albumin synthesis, albuminuria and hyperlipemia in nephrotic patients, Kidney Int. 31:1368–1376.
Short, C.D., Durrington, P.N., Mallick, N.P., Hunt, L.P., Tetlow, L., and Ishola, M., 1986, Serum and urinary high density lipoproteins in glomerular disease with proteinuria, Kidney Int. 29: 1224–1228.
Scully, R.E., Mark, E.J., McNeely, W.F., and McNeely, B.U., 1987, Case records of the Massachusetts General Hospital: Case 14-1987, N. Engl. J. Med. 316:860–869.
Valeri, A., Gelfand, J., Blum, C., and Appel, G.B., 1986, Treatment of the hyperlipidemia of the nephrotic syndrome: A controlled trial, Am. J. Kidney Dis. 8:388–396.
Mehis, O., Addrassy, K., Koderisch, J., Herzog, U., and Ritz, E., 1987, Hemostasis and thromboembolism in children with nephrotic syndrome: Differences from adults, J. Pediatr. 110:862–867.
Alkjaersig, N., Fletcher, A.P., Narayanan, M., and Robson, A.M., 1987, Course and resolution of the coagulopathy in nephrotic children, Kidney Int. 31:772–780.
Bennett, A., and Cameron, J.S., 1987, Platelet hyperaggregability in the nephrotic syndrome which is not dependent on arachidonic acid metabolism or on plasma albumin concentration, Clin. Nephrol. 27:182–188.
Strife, C.F., Jackson, E.C., Forristal, J., and West, C.D., 1986, Effect of the nephrotic syndrome on the concentration of serum complement components, Am. J. Kidney Dis. 8:37–42.
Mori, R., Triolo, L., De Stefano, V., Giusti, B.P., De Sole, P., and Leone, G., 1988, Plasma levels and loss of antithrombin III in chronic ambulatory peritoneal dialysis and nephrotic patients, Nephron 48:213–216.
Vigano-D’Angelo, S., D’Angelo, A., Kaufman, C.E., Sholer, C., Esmon, C.T., and Comp, P.C., 1987, Protein S deficiency occurs in the nephrotic syndrome, Arch. Intern. Med. 107:42–47.
Robert, A., Olmer, M., Sampol, J., Gugliotta, J., and Casanova, P., 1987, Clinical correlation between hypercoagulability and thrombo-embolic phenomenon, Kidney Int. 31:830–835.
Vermylen, C.G., Levin, M., Lanham, J.G., Hardisty, R.M., and Barratt, T.M., 1987, Decreased sensitivity to heparin in vitro in steroid-responsive nephrotic syndrome, Kidney Int. 31: 1396–1401.
Vriesendorp, R., Donker, A.J.M., de Zeeuw, D., de Jong, P.E., van der Hem, G.K., and Brentjens, J.R.H., 1986, Effects of nonsteroidal antiinflammatory durgs on proteinuria, Am. J. Med. 81:84–94.
Alavi, N., Lianos, E.A., Venuto, R.C., Mookerjee, B.K., and Bentzel, C.J., 1986, Reduction of proteinuria by indomethacin in patients with nephrotic syndrome, Am. J. Kidney Dis. 8:397–403.
Vriesendorp, R., de Zeeuw, D., de Jong, P.E., Donker, A.J.M., Pratt, J.J., and van der Hem, G.K., 1986, Reduction of urinary protein and prostaglandin E2 excretion in the nephrotic syndrome by non-steroidal anti-inflammatory drugs, Clin. Nephrol. 25:105–110.
Velosa, J.A. and Torres, V.E., 1986, Benefits and risks of nonsteroidal antiinflammatory drugs in steroid-resistant nephrotic syndrome, Am. J. Kidney Dis. 8:345–350.
Heeg, J.E., de Jong, P.E., van der Hem, G.K., and de Zeeuw, D., 1987, Reduction of proteinuria by angiotensin converting enzyme inhibition, Kidney Int. 32:78–83.
Lewis, E.J., 1987, Angiotensin-converting enzyme inhibitors: Considerations regarding proteinuria, Am. J. Kidney Dis. 10:30–38.
Lagrue, G., Robeva, R., and Laurent, J., 1987, Antiproteinuric effect of captopril in primary glomerular disease, Nephron 46:99–100.
Rapola, J., 1987, Congenital nephrotic syndrome, Pediatr. Nephrol. 1:441–446.
Morduchowicz, G., Boner, G., Ben-Basset, M., and Rosenfeld, J.B., 1986, Proteinuria in benign nephrosclerosis, Arch. Intern. Med. 146:1513–1516.
Narvarte, J., Prive, M., Saba, S.R., and Ramirez, G., 1987, Proteinuria in hypertension, Am. J. Kidney Dis. 10:408–416.
Hannedouche, T., Fournier, J.F., Moore, N., Godin, M., and Fillastre, J.P., 1986, Letters to the editor: Nephrotic syndrome due to isolated minimal change glomerular disease in a patient taking pirprofen, Clin. Nephrol. 25:314.
Beun, G.D.M., Leunissen, K.M.L., Van Brenda Vriesman, P.J.C., and Van Hooff, J.P., 1987, Isolated minimal change nephropathy associated with diclofenac, Br. Med. J. 295:182–183.
Schwartzman, M. and D’Agati, V., 1987, Spontaneous relapse of naproxen-related nephrotic syndrome, Am. J. Med. 82:329–332.
Artinano, M., Etheridge, W.B., Stroehlein, K.B., and Barcenas, C.G., 1986, Progression of minimal-change glomerulopathy to focal glomerulosclerosis in a patient with Fenoprofen nephropathy, Am. J. Nephrol. 6:353–357.
Dabbs, D.J., Striker, L., Mignon, F., and Striker, G., 1986, Glomerular lesions in lymphomas and leukemias, Am. J. Med. 80:63–70.
Huisman, R.M., de Jong, P.E., de Zeeuw, D., van Imhoff, G.W., and van der Hem, G.K., 1986, Nephrotic syndrome preceding Hodgkin’s disease by 42 months, Clin. Nephrol. 26:311–313.
Orman, S.V., Schechter, G.P., Whang-Peng, J., Guccion, J., Chan, C., Schulof, R.S., and Shalhoub, R.J., 1986, Nephrotic syndrome associated with a clonal T-cell leukemia of large granular lymphocytes with cytotoxic function, Arch. Intern. Med. 146:1827–1829.
Schroeter, N.J., Rushing, D.A., Parker, J.P., and Beltaos, E., 1986, Minimal-change nephrotic syndrome associated with malignant mesothelioma, Arch. Intern. Med. 146:1834–1836.
Nolasco, F., Cameron, J.S., Heywood, E.F., Hicks, J., Ogg, C., and Williams, D.G., 1986, Aduot-onset minimal change nephrotic syndrome: A long-term follow-up, Kidney Int. 29:1215–1223.
Allen, M.J., Thomas, A.C., and Eastwood, J.B., 1987, Minimal change glomerulonephritis in the elderly—The role of renal biopsy, Clin. Nephrol. 28:99–101.
Melvin, T. and Michael, A.F., 1986, New insights into the pathogenesis of minimal change disease, Clin. Immunol. Allergy 6:369–390.
Ghiggeri, G.M., Candiano, G., Ginevri, F., Gusmano, R., Ciardi, M.R., Perfumo, F., Delfino, G., Cuniberti, C., and Queirolo, C., 1987, Renal selectivity properties towards endogenous albumin in minimal change nephropathy, Kidney Int. 32:69–77.
Yokoyama, H., Kida, H., Abe, T., Koshino, Y., Yoshimura, M., and Hattori, N., 1987, Impaired immunoglobulin G production in minimal change nephrotic syndrome in adults, Clin. Exp. Immunol. 70:110–115.
Chan, M.K., Chan, K.W., and Jones, B., 1987, Immunoglobulins (IgG, IgA, IgM, IgE) and complement components (C3, C4) in nephrotic syndrome due to minimal change and other forms of glomerulonephritis, a clue for steroid therapy? Nephron 47:125–130.
Thomson, N.P. and Kraft, N., Chan, M.K., Chan, K.W., and Jones, B., Chan, M.K., Chan, K.W., and Jones, B., 1987, Normal human serum also contains the lymphotoxin found in minimal change nephropathy, Kidney Int. 31:1186–1193.
Kopolovic, J., Shvil, Y., Pomeranz, A., Ron, N., Rubinger, D., and Oren, R., 1987, IgM nephropathy: Morphological study related to clinical findings, Am. J. Nephrol. 7:275–280.
Lin, C. and Chu, C., 1986, Studies of circulating immune complexes and lymphocyte subpopulations in childhood IgM mesangial nephropathy, Nephron 44:198–203.
Border, W.A., 1988, Distinguishing minimal-change disease from mesangial disorders, Kidney Int. 34:419–434.
Korbet, S.M., Schwartz, M.M., and Lewis, E.J., 1986, The prognosis of focal segmental glomerular sclerosis of adulthood, Medicine 65:304–311.
Miyata, J., Takebayashi, S., Taguchi, T., Naito, S., and Harada, T., 1986, Evaluation and correlation of clinical and histological features of focal segmental glomerulosclerosis, Nephron 44: 115–120.
Claris-Appiani, A., Galato, R., Marra, G., Assael, B.M., and Seveso, M., 1986, Prediction of the progression of renal failure in adult and in pediatric patients with malignant focal glomerulosclerosis, Clin. Nephrol. 26:87–90.
Verani, R.R., and Hawkins, E.P., 1986, Recurrent focal segmental glomerulosclerosis: A pathological study of the early lesion, Am. J. Nephrol. 6:263–270.
Striegel, J.E., Sibley, R.K., Fryd, D.S., and Mauer, S.M., 1986, Recurrence of focal segmental sclerosis in children following renal transplantation, Kidney Int. 30:S44–S50.
Kasiske, B.L. and Crosson, J.T., 1986, Renal disease in patients with massive obesity, Arch. Intern. Med. 146:1105–1109.
Jennette, J.C., Charles, L., and Grubb, W., 1987, Glomerulomegaly and focal segmental glomerulosclerosis associated with obesity and sleep-apnea syndrome, Am. J. Kidney Dis. 10:470–472.
Gaber, L.W. and Spargo, B.H., 1987, Pregnancy-induced nephropathy: The significance of focal segmental glomerulosclerosis, Am. J. Kidney Dis. 9:317–323.
Rao, T.K.S., Friedman, E.A., and Nicastri, A.D., 1987, The types of renal disease in the acquired immunodeficiency syndrome, N. Engl. J. Med. 316:1062–1068.
Chander, P., Soni, A., Suri, A., Bhagwat, R., Yoo, J., and Tresar, G., 1987, Renal ultrastructural markers in AIDS-associated nephropathy, Am. J. Pathol. 126:513–526.
Pardo, V., Meneses, R., Ossa, L., Jaffe, D.J., Strauss, J., Roth, D., and Bourgoignie, J.J., 1987, AIDS-related glomerulopathy: Occurrence in specific risk groups, Kidney Int. 31:1167– 1173.
Humphreys, M.H. and Schoenfeld, P.Y., 1987, Renal complications in patients with the acquired immune deficiency syndrome (AIDS), Am. J. Nephrol. 7:1–7.
Humphreys, M.H. and Schoenfeld, P.Y., 1987, AIDS and renal disease, Kidney 20:7–12.
Nurse, H., 1987, Heroin and nephropathy, Transplant. Proc. 14:56.
May, D.C., Helderman, J.H., Eigenbrodt, E.H., and Silva, F.G., 1986, Chronic sclerosing glomerulopathy (heroin-associated nephropathy) in intravenous T’s and blues abusers, Am. J. Kidney Dis. 8:404–409.
Lin, C. and Hsu, H., 1986, Histopathological and immunological studies in spontaneous remission of nephrotic syndrome after intercurrent measles infection, Nephron 42:110–115.
Nair, R.B., Date, A., Kirubakaran, M.G., and Shastry, J.C.M., 1987, Minimal-change nephrotic syndrome in adults treated with alternate-day steroids, Nephron 47:209–210.
Wetzels, J.F.M., Gerlag, P.G.G., Sluiter, H.E., Hoitsma, A.J., and Koene, R.A.P., 1986, prednisone-induced fluctuations of proteinuria in patients with a nephrotic syndrome, Nephron 44: 344–350.
Garcia, D.L., Rennke, H.G., Brenner, B.M., and Anderson, S., 1987, Chronic glucocorticoid therapy amplifies glomerular injury in rats with renal ablation, J. Clin. Invest. 80:867–874.
Tejani, A., 1987, Relapsing nephrotic syndrome, Nephron 45:81–85.
Niaudet, P., Habib, R., Tete, M., Hinglais, N., and Broyer, M., 1987, Cyclosporin in the treatment of idiopathic nephrotic syndrome in children, Pediatr. Nephrol. 1:566–573.
Tejani, A., 1987, Cyclosporine treatment in patients with primary glomerular disease, Int. J. Pediatr. Nephrol. 8:1–3.
Tejani, A., Butt, K., Trachtman, H., Suthanthiran, M., Rosenthal, C.J., and Khawar, M.R., 1987, Cyclosporine-induced remission of relapsing nephrotic syndrome in children, J. Pediatr. 111:1056–1062.
Waldo, F.B. and Kohaut, E.C., 1987, Therapy of focal segmental glomerulosclerosis with cyclosporine A, Pediatr. Nephrol. 1:180–182.
Hoyer, P.F., Krull, J., and Brodehl, J., 1986, Letters to the editor: Cyclosporine in frequently relapsing minimal change nephrotic syndrome, Lancet 9:335.
Oemar, B.S. and Brodehl, J., 1987, Cyclophosphamide treatment of steroid dependent nephrotic syndrome: Comparison of eight weeks with 12 week course, Arch. Dis. Childhd. 62:1102–1106.
Trompeter, R.S., 1986, Minimal change nephrotic syndrome and cyclophosphamide, Arch. Dis. Childhood 61:727–729.
Pei, Y., Cattran, D., Delmore, T., Katz A., Lang, A., and Ranee, P., 1987, Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis, Am. J. Med. 82:938–944.
Griswold, W.R., Tune, B.M., Tune, B.M., Reznik, V.M., Vazquez, M., Prime, D.J., Brock, P., and Mendoza, S.A., 1987, Treatment of childhood prednisone-resistant nephrotic syndrome and focal segmental glomerulosclerosis with intravenous methylprednisolone and oral alkylating agents, Nephron 46:73–77.
MacTier, R., Jones, J.M.B., Payton, C.D., and McLay, A., 1986, The natural history of membranous nephropathy in the west of Scotland, Q.J. Med. 60:793–802.
Kida, H., Asamoto, T., Yokoyama, H., Tomosugi, N., and Hattori, N., 1986, Long-term prognosis of membranous nephropathy, Clin. Nephrol. 25:64–69.
Tornroth, T., Honkanen, E., and Pettersson, E., 1987, The evolution of membranous glomerulonephritis reconsidered: new insights from a study on relapsing disease, Clin. Nephrol. 28:107–117.
Brueggemeyer, C.D. and Ramirez, G., 1987, Membranous nephropathy: A concern for malignancy, Am. J. Kidney Dis. 9:23–26.
Packham, D.K., North, R.A., Fairley, K.F., Whitworth, J.A., and Kincaid-Smith, P., 1987, Membranous glomerulonephritis and pregnancy, Clin. Nephrol. 28:56–64.
Abreo, K., Abreo, F., Mitchell, B., and Schloemer, G., 1986, Idiopathic crescentic membranous glomerulonephritis, Am. J. Kidney Dis. 8:257–261.
Papiha, S.S., Pareek, S.K., Rodger, R.S.C., Morley, A.R., Wilkinson, R., Roberts, D.F., and Kerr, D.N.S., 1987, HLA-A, B, and Bf allotypes in patients with idiopathic membranous nephropathy (IMN), Kidney Int. 31:130–134.
Roccatello, D., Coppo, R., Amoroso, A., Curtoni, E.S., Martina, G., Basolo, B., Amore, A., Rollino, C., Picciotto, G., Cordonnier, D., Sena, L., and Piccoli, G., 1987, Failure to relate mononuclear phagocyte system function to HLA-A, B, C, DR, DQ antigens in membranous nephropathy, Am. J. Kidney Dis. 9:470–475.
Couser, W.G. and Abrass, C.K., 1988, Pathogenesis of membranous nephropathy, Am. Rev. Med. 39:517–530.
Verroust, P., Ronco, P., and Chatelet, F., 1987, Antigenic targets in membranous glomerulonephritis, Springer Semin. Immunopathol. 9:341–358.
Cosyns, J.P., Katatchkine, M.D., Bhakdi, S., Mandet, C., Grossetete, J., Hinglais, N., and Bariety, J., 1986, Immunohistochemical analysis of C3 cleavage fragments, factor H, and C5b-9 terminal complex of complement in de novo membranous glomerulonephritis occurring in patients with renal transplant, Clin. Nephrol. 26:203–208.
Weildner, N. and Lorentz, W.B., 1986, Scanning electron microscopy of the acellular glomerular basement membranes in idiopathic membranous glomerulopathy, Lab. Invest. 154:84–92.
Okada, K., Kawakami, K., Miyao, M., and Oite, T., 1986, Ultrastructural alterations of glomerular anionic sites in idiopathic membranous glomerulonephritis, Clin. Nephrol. 26:7–14.
Shemesh, O., Ross, J.C., Deen, W.M., Grant, G.W., and Myers, B.D., 1986, Nature of the glomerular capillary injury in human membranous glomerulopathy, J. Clin. Invest. 77:868–877.
Couser, W.G., 1988, Pathogenesis and theoretical basis for treatment of membranous nephropathy, in: Nephrology, Volume 2 (A.M. Davison, ed.), Bailliere Tindall, London, pp. 701–713.
Noble, B., Van Liew, J.B., and Brentjens, J.R., 1986, A transition from proliferative to membranous glomerulonephritis in chronic serum sickness, Kidney Int. 29:841–848.
Ponticelli, C., Zucchelli, P., and Passerini, P., 1987, Therapy of idiopathic membranous nephropathy, Springer Semin. Immunopathol. 9:431–440.
Zucchelli, P., Cagnoli, L., Pasquali, S., Casanova, S., and Donini, U., 1986, Clinical and morphologic evolution of idiopathic membranous nephropathy, Clin. Nephrol. 25:282–288.
Garattini, S., Bertani, T., and Remuzzi, G., 1987, What is the basis for the use of steroids in the treatment of idiopathic membranous nephropathy? Nephron 45:1–6.
Short, C.D., Solomon, L.R., Gokal, R., and Mallick, N.P., 1987, Methylprednisolone in patients with membranous nephropathy and declining renal function, Q.J. Med. 65:929–940.
Grekas, D., Kalekou, H., Tsakalos, N., and Tourkantonis, A., 1987, Can cyclophosphamide pulse therapy change the natural course of idiopathic glomerulopathy resistant to steroids? Nephron 47: 236–237.
DeSanto, N.G., Capodicasa, G., and Giordano, C., 1987, Treatment of idiopathic membranous nephropathy unresponsive to methylprednisolone and chlorambucil with cyclosporin, Am. J. Nephrol. 7:74–76.
West, M.L., Jindal, K.K., Bear, R.A., and Goldstein, M.B., 1987, A controlled trial of cyclophosphamide in patients with membranous glomerulonephritis, Kidney Int. 32:579–584.
Makker, S.P., 1986, Hepatitis B associated membranous glomerulonephropathy, Indian J. Pediatr. 53:317–325.
Editorial, 1987, HBV and glomerulonephritis, Lancet 1:252–253.
Sennesael, J., Van den Houte, K., and Verbeelen, D., 1986, Reversible membranous glomerulonephritis associated with ketoprofen, Clin. Nephrol. 26:213–215.
Yokoyama, H., Kida, H., Asamato, T., Abe, T., Koshino, Y., and Hattori, N., 1986, Gouty kidney associated with membranous nephropathy: Participation of renal tubular epithelial antigen, Nephron 44:361–364.
Higuchi, A., Suzuki, Y., and Okado, T., 1987, Membranous glomerulonephritis in rheumatoid arthritis unassociated with gold or penicillamine treatment, Ann. Rheumat. Dis. 46:488–490.
Hall, C.L., Fothergill, N.J., Blackwell, M.M., Harrison, P.R., MacKenzie, J.C., and Maclver, A.G., 1987, the natural course of gold nephropathy: Long term study of 21 patients, Br. Med. J. 295:745–748.
Collins, A.J., 1987, Glod treatment for rheumatoid arthritis: Reassurance on protein uria, Br. Med. J. 295:739–740.
Rosenmann, E., Brisson, M.L., Bercovitch, D.D., and Rosenberg, A., 1988, Atypical membranous glomerulonephritis with fibrillar subepithelial deposits in a patient with malignant lymphoma, Nephron 48:226–230.
Murphy, B.F., Gonzales, M.F., Ebeling, P., Fairley, K.F., and Kincaid-Smith, P., 1986, Membranous glomerulonephritis and Landry-Guillain-Barre syndrome, Am. J. Kidney Dis. 8: 267–270.
Welch, T.R., Beischel, L., Balakrishnan, K., Quinlan, M., and West, C.D., 1986, Majorhistocompatibility- complex extended haplotypes in membranoproliferative glomerulonephritis, N. Engl. J. Med. 314:1476–1481.
Stutchfield, P.R., White, R.H.R., Cameron, A.H., Thompson, R.A., Mackintosh, P., and Wells, L., 1986, X-linked mesangiocapillary glomerulonephritis, Clin. Nephrol. 26:15–156.
Jackson, E.C., McAdams, A.J., Strife, C.F., Forristal, J., Welch, T.R., and West, C.D., 1987, Differences between membranoproliferative glomerulonephritis types I and III in clinical presentation, glomerular morphology, and complement perturbation, Am. J. Kidney Dis. 9:115–120.
Korzets, Z., Bernheim, J., and Bernheim, J., 1987, Rapidly progressive glomerulonephritis (crescentic glomerulonephritis) in the course of type I idiopathic membranoproliferative glomerulonephritis, Am. J. Kidney Dis. 10:56–61.
Glicklich, D., Matas, A.J., Sablay, L.B., Senitzer, D., Tellis, V.A., Soberman, R., and Veith, F.J., 1987, Recurrent membranoproliferative glomerulonephritis type I in successive renal transplants, Am. J. Nephrol. 7:143–149.
West, C.D., 1986, Childhood membranoproliferative glomerulonephritis: An approach to management, Kidney Int. 29:1077–1093.
Sato, H., Saito, T., Seino, J., Ootaka, T., Kyogoku, Y., Furuyama, T., and Yoshinaga, K., 1987, Dense deposit disease: Its possible pathogenesis suggested by an observation of a patient, Clin. Nephrol. 27:41–45.
Pober, J.S., Lapierre, L.A., Stolpen, A.H., Brock, T.A., Springer, T.A., Fiers, W., Bevilacqua, P., Mendrick, D.L., and Gibrone, M.A. Jr., 1987, Activation of cultured human endothelial cells by recombinant lymphotoxin: Comparison with tumor necrosis factor and interleukin 1 species, J. Immunol. 138:3319–3324.
Cotran, R.S., Pober, J.S., Gimbrone, M.A. Jr., Springer, T.A., Wiebke, E.A., Gaspari, A.A., Rosenberg, S.A., and Lotze, M.T., 1987, Endothelial activation during interleukin 2 immunotherapy: A possible mechanism for the vascular leak syndrome, J. Immunol. 139:1883–1888.
Leung, D.Y.M., Geha, R.S., Newburger, J.W., Burns, J.C., Fiers, W., Lapierre, L.A., and Pober, J.S., 1986, Two monkines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells subsceptible to lysis by antibodies circulating during Kawasaki syndrome, J. Exp. Med. 164:1958–1972.
Moyer, C.F., Strandberg, J.D., and Reinisch, C.L., 1987, Systemic mononuclear-cell vasculitis in MRL/Mp-lpr/lpr mice: A histological and immunocytochemical analysis, Am. J. Pathol. 127: 229–242.
Adu, D., Howie, A.J., Scott, D.G.I., Bacon, P.A., McGonigle, R.J.S., and Michael, J., 1987, Polyarteritis and the kidney, Q.J. Med. 62:221–237.
Ramirez, G., Saba, S.R., and Espinoza, L., 1987, Hypocomplementemic vasculitis and renal involvement, Nephron 45:147–150.
Kuznetsky, K.A., Schwartz, M.M., Lohmann, L.A., and Lewis, E.J., 1986, Necrotizing glomerulonephritis in rheumatoid arthritis, Clin. Nephrol. 26:257–264.
Chang-Miller, A., Okamura, M., Torres, V.E., Michet, C.J., Wagoner, R.D., Donadio, J.V., Offord, K.P., and Holley, K.E., 1987, Renal involvement in relapsing polychondritis, Medicine 66:202–217.
Longley, S., Caldwell, J.R., and Panush, R.S., 1986, Paraneoplastic Vasculitis: Unique syndrome of cutaneous angiitis and arthritis associated with myeloproliferative disorders, Am. J. Med. 80:1027–1030.
Balow, J.E., Austin, H.A., Tsokos, G.C., Antonovych, T.T., Steinberg, A.D., andKlippel, J.H., 1987, Lupus nephritis, Ann. Intern. Med. 106:79–94.
Dillard, M.G., 1987, Systemic lupus erythematosus—The nephrologist’s viewpoint, Transplant. Proc. 19:57–59.
Leaker, B., Fairley, K.F., Dowling, J., and Kincaid-Smith, P., 1987, Lupus nephritis: Clinical and pathological correlations, Q.J. Med. 62:163–179.
Rush, P.J., Baumal, R., Shore, A., Balfe, J.W., and Schreiber, M., 1986, Correlation of renal histology with outcome in children with lupus nephritis, Kidney Int. 29:1066–1071.
Lewis, E.J., Kawala, K., and Schwartz, M.M., 1987, Histologic features that correlate with the prognosis of patients with lupus nephritis, Am. J. Kidney Dis. 10:192–197.
Schwartz, M.M., Kawala, K.S., Corwin, H.L., and Lewis, E.J., 1987, The prognosis of segmental glomerulonephritis in systemic lupus erythematosus, Kidney Int. 32:274–279.
Kasinath, B.S., Nielson, E.G., Hebert, L., Schwartz, M.M., Lewis, E.J., etal., 1986, Shortterm prognosis of severe proliferative lupus nephritis, Am. J. Kidney Dis. 8:239–243.
Ponticelli, C., Zucchelli, P., Morini, G., Cagnoli, L., Banfi, G., and Pasquali, S., 1987, Longterm prognosis of diffuse lupus nephritis, Clin. Nephrol. 28:263–271.
Henry, R., Williams, A.V., McFadden, N.R., and Pilia, P.A., 1986, Histopathologic evaluation of lupus patients with transient renal failure, Am. J. Kidney Dis. 8:417–421.
Font, J., Torras, A., Cervera, R., Darnell, A., Revert, L., and Ingelmo, M., 1987, Silent renal disease in systemic lupus erythematosus, Clin. Nephrol. 27:283–288.
Park, M.H., Agati, V.D., Appel, G.B., and Pirani, C.L., 1986, Tubulointerstitial disease in lupus nephritis: relationship to immune deposits, interstitial inflammation, glomerular changes, renal function, and prognosis, Nephron 44:309–319.
Averbuch, M., Koifman, B., and Levo, Y., 1987, Lupus anticoagulant, thrombosis and thrombocytopenia in systemic lupus erythematosus, Am. J. Med. Sci. 393:1–5.
Norberg, R., Nived, O., Sturfelt, G., Unander, M., and Arfors, L., 1987, Anticardiolipin and complement activation: relation to clinical symptoms, J. Rheumatol. 14:149–153.
Lenzi, R., Rand, H.J., and Spiera, H., 1986, Anticardiolipin antibodies in pregnant patients with systemic lupus erythematosus, N. Engl. J. Med. 314:1392–1393.
Petri, M., Rheinschmidt, M., Whiting-O’Keefe, Q., Hellmann, D., and Corash, L., 1987, The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level, Ann. Intern. Med. 106:524–531.
Lockshin, M.D., Druzin, M.L., Goei, S., Qamar, T., Magid, M.S., Jovanovic, L., and Ferenc, M., 1985, Antibody to cardiolipin as predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus, N. Engl. J. Med. 313:152–156.
Howard, M.A., Firkin, B.G., Healy, D.L., and Choong, S-C.C., 1987, Lupus anticoagulant in women with multiple spontaneous miscarriage, Am. J. Hematol. 26:175–178.
Bobie, G., Liote, F., Houillier, P., Grunfeld, J.P., and Jungers, P., 1987, Pregnancy in lupus nephritis and related disorders, Am. J. Kidney Dis. 9:339–343.
Roth, D., Milgrom, M., Esquenazi, V., Strauss, J., Zilleruelo, G., and Miller, J., 1987, Renal transplantation in systemic lupus erythematosus: one center’s experience, Am. J. Nephrol. 7:367– 374.
Kumano, K., Sakai, T., Mashimo, S., Endo, T., Koshiba, K., Elises, J.S., and Iitaka, K., 1987, A case of recurrent lupus nephritis after renal transplantation, Clin. Nephrol. 27:94–98.
Pollock, C.A. and Ibels, L.S., 1987, Dialysis and transplantation in patients with renal failure due to systemic lupus erythematosus. The Australian and New Zealand experience, Aust. NZJ. Med. 17:321–325.
Rodby, R.A., Korbet, S.M., and Lewis, E.J., 1987, Persistence of clinical and serologic activity in patients with systemic lupus erythematosus undergoing peritoneal dialysis, Am. J. Med. 83:613–618.
Emlen, W., Pisetsky, D.S., and Taylor, R.P., 1986, Antibodies to DNA, a perspective, Arthritis Rheum. 29:1417–1426.
Hahn, B.H. and Ebling, F.M., 1987, Idiotype restriction in murine lupus; high frequency of three public idioptypes on serum IgG in nephritic NZB/NZW Fj mice, J. Immunol. 138:2110–2118.
Gavalchin, J., Seder, R.A., and Datta, S.K., 1987, The NZB x SWR model of lupus nephritis, J. Immunol. 138:128–137.
Madaio, M.P., Schattner, A., Shattner, M., and Schwartz, R.S., 1986, Lupus serum and normal human serum contain anti-DNA antibodies with the same idiotypic marker, J. Immunol. 137: 2535–2540.
Madaio, M.P., Carlson, J., Cataldo, J., Ucci, A., Migliorini, P., and Pankewycz, O., 1987, Murine monoclonal anti-DNA antibodies bind directly to glomerular antigens and form immune deposits, J. Immunol. 138:2883–2889.
Pankewycz, O.G., Migliorini, P., and Madaio, M.P., 1987, Polyreactive autoantibodies are nephritogenic in murine lupus nephritis, J. Immunol. 139:3287–3294.
Hashemi, S., Smith, C.D., and Izaguirre, C.A., 1987, Anti-endothelial cell antibodies: Detection and characterization using a cellular enzyme-linked immunosorbent assay, J. Lab. Clin. Med. 109: 434–440.
Helin, H., Korpela, M., Mustonen, J., and Pasternack, A., 1986, Rheumatoid factor in rheumatoid arthritis associated renal disease and in lupus nephritis, Ann. Rheum. Dis. 45:508–511.
Stetler, D.A. and Cavallo, T., 1987, Anti-RNA polymerase I antibodies: Potential role in the induction and progression of murine lupus nephritis, J. Immunol. 138:2119–2123.
Cosio, F.G., Hebert, L.A., Birmingham, D.J., Dorval, B.L., Bakaletz, A.P., Kujala, G.A., Edberg, J.C., and Taylor, R.P., 1987, Clearance of human antibody/DNA immune complexes and free DNA from the circulation of the nonhuman primate, Clin. Immunol. Immunopathol. 42:1–9.
Horgan, C. and Emlen, W., 1987, Complement fixation by small, DNase-resistant DNA-anti- DNA immune complexes, Mol. Immunol. 24:109–116.
Taylor, R.P., Edberg, J.C., Kujala, G.A., and Sloman, A.J., 1987, The interaction of antibody/DNA immune complexes with complement, Arthritis Rheum. 30:176–185.
Greisman, S.G., Redecha, P.B., Kimberly, R.P., and Christian, C.L., 1987, Differences among immune complexes: Association of Clq in SLE immune complexes with renal disease, J. Immunol. 138:739–745.
Uwatoko, S., Aotsuka, S., Okawa, M., Egusa, Y., Yokohari, R., Aizawa, C., and Suzuki, K., 1987, Clq solid-phase radioimmunoassay: Evidence for detection of antibody directed against the collagen-like region of Clq in sera from patients with systemic lupus erythematosus, Clin. Exp. Immunol. 69:98–106.
Zanetti, M., 1986, New concepts in autoimmunity, Immunol. Invest. 15:287–310.
Eilat, D., 1986, Anti-DNA antibodies: Problems in their study and interpretation, Clin. Exp. Immunol. 65:215–222.
Jacob, L., Lety, M-A., Bach, J-F., and Louvard, D., 1986, Human systemic lupus erythematosus sera contain antibodies against cell-surface protein(s) that share(s) epitope(s) with DNA, Immunology 83:6970–6974.
Balow, J.E., 1986, Lupus nephritis: Natural history, prognosis and treatment, Clin. Immunol. Allergy 6:391–404.
Miescher, P.A., 1986, Treatment of systemic lupus erythematosus, Springer Semin. Immunopathol. 9:271–282.
Steinberg, A.D., 1986, The treatment of lupus nephritis, Kidney Int. 30:769–787.
Austin, H.A., Klippel, J.H., Balow, J.E., Le Riche, N.G.H., Steinberg, A.D., Plotz, P.H., and Decker, J.L., 1986, Therapy of lupus nephritis controlled trial of prednisone and cytotoxic drugs, N. Engl. J. Med. 314:614–619.
Felson, D.T. and Anderson, J., 1986, Treatment of lupus nephritis, N. Engl. J. Med. 315:458–459.
Schroeder, J.O., Euler, H.H., and Loffler, H., 1987, Synchronization of plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus, Ann. Intern. Med. 107:344–346.
Jordan, S.C., Ho, W., Ettenger, R., Salusky, I.B., and Fine, R.N., 1987, Plasma exchange improves glomerulonephritis of systemic lupus erythematosus in selected pediatric patients, Pediatr. Nephrol. 1:276–280.
Hebert, L., Nielsen, E., Pohl, M., Lachin, J., Hunsicker, L., and Lewis, E.J., 1987, Clinical course of severe lupus nephritis during the controlled clinical trial of plasmapheresis therapy (PPT), Kidney Int. 31:201 (Abstract).
Lewis, E.J. and Lachin, J., 1987, Primary outcomes in the controlled trial of plasmapheresis therapy (PPT) in severe lupus nephritis, Collaborative Study Group (LNCSG), Kidney Int. 31:208 (Abstract).
Edwards, J.C.W., Snaith, M.L., and Isenberg, D.A., 1987, A double blind controlled trial of methylprednisolone infusions in systemic lupus erythematosus using individualised outcome assessment, Ann. Rheum. Dis. 46:773–776.
Gunn, H.C., 1986, Successful treatment of autoimmunity in (NZB x NZW) F, mice with cyclosporin and (Nva2)-cyclosporin: I. Reduction of autoantibodies, Clin. Exp. Immunol. 64:225–233.
Gunn, H.C. and Ryffel, B., 1986, Successful treatment of autoimmunity in (NZB x NZW)F1 mice with cyclosporin and (Nva2)-cyclosporin: II. Reduction of glomerulonephritis, Clin. Exp. Immunol. 64:234–242.
Miescher, P.A., Favre, H., Chatelanat, F., and Mihatsch, M.J., 1987, Combined steroidcyclosporin treatment of chronic autoimmune diseases, Klin. Wochenschr. 65:727–736.
Kotzin, B.L., Arndt, R., Okada, S., Ward, R., Thach, A.B., and Strober, S., 1986, Treatment of NZB/NZW mice with total lymphoid irradiation: Long-lasting suppression of disease without generalized immune suppression, J. Immunol. 136:3259–3271.
Strober, S., Farinas, C., Field, E.H., Solovera, J.J., Kiberd, B.A., Myers, B.D., and Hoppe, R.T., 1987, Lupus nephritis after total lymphoid irradiation: Persistent improvement and reduction of steroid therapy, Ann. Intern. Med. 107:689–690.
Boushey, H.A., Warnock, D.G., and Smith, L.H., 1987, New approaches to treating systemic lupus erythematosus, West J. Med. 147:181–186.
Klinman, D. M,. Lefkowitz, M.D., Raveche, E.S., and Steinbert, A.D., 1986, Effect of anti-la treatment on the production of anti-DNA antibody by NZB mice, Eur. J. Immunol. 16:939–944.
Epstein, A., Greenberg, M., Diamond, B., and Grayzel, A.I., 1987, Suppression of anti-DNA antibody synthesis in vitro by a cross-reactive antiidiotype antibody, J. Clin. Invest. 79:997–1000.
Milner, L.S., De Chadarevian, J-P., Goodyer, P.R., Mills, M., and Kaplan, B.S., 1987, Amelioration of murine lupus nephritis by dimethylsulfoxide, Clin. Immunol. Immunopathol. 45: 259–267.
Alexander, N.J., Smythe, N.L., and Jokinen, M.P., 1987, The type of dietary fat affects the severity of autoimmune disease in NZB/NZW mice, Am. J. Pathol. 127:106–121.
Lee, H.S., Koh, H.I., Kim, M.J., and Rha, H.Y., 1986, Henoch-Schoenlein nephritis in adults: A clinical and morphological study, Clin. Nephrol. 26:125–130.
Walker, R.J., Bailey, R.R., Lynn K.L., and Swainson, C.P., 1986, Henoch-Schonlein nephritis, NZ Med. J. 99:534–535.
Montoliu, J., Miro, J.M., Campistol, J.M., Trilla, A., Mensa, J., Torras, A., and Revert, L., 1987, Henoch-Schönlein purpura complicating staphylococcal endocarditis in a heroin addict, Am. J. Nephrol. 7:137–139.
Shichiri, M., Tsutsumi, K., Yamamoto, I., Ida, T., and Iwamoto, H., 1987, Diffuse intrapulmonary hemorrhage and renal failure in adult Henoch-Schonlein purpura, Am. J. Nephrol. 7:140–142.
Nast, C.C., Ward, H.J., Koyle, M.A., and Cohen, A.H., 1987, Recurrent Henoch-Schonlein purpura following renal transplantation, Am. J. Kidney Dis. 9:39–43.
Smolens, P., 1987, The kidney in dysproteinemic states, AKF Nephrol. Letter 40:27–42.
Cordonnier, D.J., Renversez, J.C., Vialtel, P., and Dechelette, E., 1987, The kidney in mixed cryoglobulinemias, Springer Semin. Immunopathol. 9:395–415.
Perez, G.O., Pardo, V., and Fletcher, M-A., 1987, Renal involvement in essential mixed cryoglobulinemia, Am. J. Kidney Dis. 10:276–280.
Ferri, C., Moriconi, L., Gremignai, G., Migliorini, P., Paleologo, G., Fosella, P.V., and Bombardieri, S., 1986, Treatment of the renal involvement in mixed cryoglobulinemia with prolonged plasma exchange, Nephron 43:246–253.
Jacquot, C., Nochy, D., D’Auzac, C., Durandy, A., Regnier, A., Lemann, M., Druet, P.H., and Bariety, J., 1987, Glomerulonephritis, B monoclonal small lymphocytic lymphoma and mixed cryoglobulinemia, Clin. Nephrol. 27:263–268.
Alpers, C.E., Rennke, H.G., Hopper, J., and Biava, C.G., 1987, Fibrillary glomerulonephritis: An entity with unusual immunofluorescence features, Kidney Int. 31:781–789.
Wahls, T.L., Bonsib, S.M., and Schuster, V.L., 1987, Coexistent Wegener’s granulomatosis and anti-glomerular basement membrane disease, Hum. Pathol. 18:202–205.
West, B.C., Todd, J.R., and King, J.W., 1987, Wegener granulomatosis and trimethoprimsulfamethoxazole, Ann. Intern. Med. 106:840–842.
Habib, R., Antignac, C., Hinglais, N., Gagnadoux, M-F., and Broyer, M., 1987, Glomerular lesions in the transplanted kidney in children, Am. J. Kidney Dis. 10:198–207.
Neild, G., 1987, The haemolytic uraemic syndrome: a review, Q.J. Med. 63:367–376.
Kaplan, B.S. and Proesmans, W., 1987, The hemolytic uremic syndrome of childhood and its variants, Semin. Hematol. 24:148–160.
Remuzzi, G., 1987, HUS and TTP: Variable expression of a single entity, Kidney Int. 32:292– 308.
Tarr, P.I. and Hickman, R.O., 1987, Hemolytic uremic syndrome epidemiology: A populationbased study in King County, Washington, 1971 to 1980, Pediatrics 80:41–45.
Taylor, C.M., White, R.H.R., Winterborn, M.H., and Rowe, B., 1986, Haemolytic-uraemic syndrome:Clinical experience of an outbreak in the West Midlands, Br. Med. J. 292:1513–1516.
White, D.J., Yong, F., and McKendrick, M.W., 1988, Haemolytic uraemic syndrome in adults, Br. Med. J. 296:899.
Carter, A.O., Borczyk, A.A., Carlson, J.A.K., Harvey, B., Hockin, J.C., Karmali, M.A., Krishnan, C., Korn, D.A., and Lior, H., 1987, A severe outbreak of Escherichia coli 0157:H7- associated hemorrhagic colitis in a nursing home, N. Engl. J. Med. 317:1496–500.
Dzik, W.H., Goergi, B.A., Khettry, U., and Jenkins, R.L., 1987, Cyclosporine-associated thrombotic thrombocytopenic purpura following liver transplantation-successful treatment with plasma exchange, Transplantation 44:570–572.
Craig, J.I.O. and Sheehan, T., 1987, The haemolytic uraemic syndrome and bone marrow transplantation, Br. Med. J. 295:887.
Jain, S. and Seymour, A.E., 1987, Mitomycin C associated hemolytic uremic syndrome, Pathology 19:58–61.
Hostetter, A.L., Tubbs, R.R., Ziegler, T., Gephardt, G.N., McMahon, J.T., and Schreiber, M.L., 1986, Chronic glomerular microangiopathy complicating metastatic carcinoma, Hum. Pathol. 18:342–348.
Remuzzi, G., Zoja, C., de Gaetano, G., and Rossi, E.C., 1987, Prostacyclin and hemolytic uremic syndrome: From the laboratory to an international registry, Int. J. Artificial Organs 10: 337–340.
Powell, H.R., Groves, V., McCredie, D.A., Yong, A., and Pitt, J., 1987, Low red cell arachidonic acid in hemolytic uremic syndrome, Clin. Nephrol. 27:8–10.
Hautekeete, M.L., Nagler, J.M., Cuykens, J.J., Parizel, G., Laekeman, G.M., and Herman, A.G., 1986, 6-keto-PGFla levels and prostacyclin therapy in 2 adult patients with hemolytic-uremic syndrome, Clin. Nephrol. 26:157–159.
Levin, M., Walters, M.D.S., Waterfield, M.D., Stroobant, P., Cheng, D.J., and Barratt, T.M., 1986, Platelet-derived growth factors as possible mediators of vascular proliferation in the sporadic haemolytic uraemic syndrome, Lancet 2:830–833.
Cosio, F.G., Eddy, A., Mentser, M.I., and Bergstein, J.M., 1985, Decreased plasma fibronectin levels in children with hemolytic-uremic syndrome, Am. J. Med. 78:549–554.
Meroni, M., Volpi, A., Battini, G., Conte, F., Ferrario, G., Giordano, F., Tarelli, L.T., Tommasi, A., and Sessa, A., 1986, Recurrent hemolytic uremic syndrome: case report, Nephron 44:263–264.
Rose, M. and Eldor, A., 1987, High incidence of relapses in thrombotic thrombocytopenic purpura, Am. J. Med. 83:437–444.
Hebert, D., Sibley, R.K., and Mauer, S.M., 1986, Recurrence of hemolytic uremic syndrome in renal transplant recipients, Kidney Int. 30:S51–S58.
Shepard, K.V. and Bukowski, R.M., 1987, The treatment of thrombotic thrombocytopenic purpura with exchange transfusions, plasma infesions, and plasma exchange, Semin. Hematol. 24: 178–193.
Lichtin, A.E., Schreiber, A.D., Hurwitz, S., Willoughby, T.L., and Silberstein, L.E., 1987, Efficacy of intensive plasmapheresis in thrombotic thrombocytopenic purpura, Arch. Intern. Med. 147:2122–2126.
Finn, N.G., Wang, J.C., and Hong, K.J., 1987, High-dose intravenous 7-immunoglobulin infusion in the treatment of thrombotic thrombocytopenic purpura, Arch. Intern. Med. 147:2165–2167.
Emancipator, S.M. and Schena, F.P., 1987, IgA nephropathy, Seminars in Nephrology 7:274–318.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Publishing Corporation
About this chapter
Cite this chapter
Couser, W.G. (1989). Immunologic Aspects of Renal Disease. In: Klahr, S., Massry, S.G. (eds) Contemporary Nephrology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0829-4_7
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0829-4_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8103-0
Online ISBN: 978-1-4613-0829-4
eBook Packages: Springer Book Archive